Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________

FORM 10-Q

__________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

			For the quarterly period ended June 30, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

			For the transition period from to

Commission file number 001-33493

____________________________________________________________________________________

GREENLIGHT CAPITAL RE, LTD.

(Exact name of registrant as specified in its charter)

____________________________________________________________________________________


Cayman Islands			N/A
(State or other jurisdiction of incorporation or organization)			(I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman Islands			KY1-1205
(Address of principal executive offices)			(Zip code)

(205) 291-3440

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Ordinary Shares	GLRE	Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


Ordinary Shares, $0.10 par value			35,321,144
(Class)			Outstanding at August 2, 2024

GREENLIGHT CAPITAL RE, LTD.

TABLE OF CONTENTS


		Page
PART I — FINANCIAL INFORMATION
	Note on Forward-Looking Statements	3
Item 1.	Financial Statements	4
	Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023	4
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 (unaudited)	5
	Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and six months ended June 30, 2024 and 2023 (unaudited)	6
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (unaudited)	7
	Notes to the Condensed Consolidated Financial Statements (unaudited)	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	41
Item 4.	Controls and Procedures	41
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	42
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	43
SIGNATURES		43

Return to table of contents

PART I — FINANCIAL INFORMATION

NOTE OF FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (herein referred as “Form 10-Q”) of Greenlight Capital Re, Ltd. (“Greenlight Capital Re,” “Company,” “us,” “we,” or “our”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical facts included in this report, including statements regarding estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements”. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the United States (“U.S.”) federal securities laws established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are not historical facts, and are based on current expectations, estimates and projections, and various assumptions, many of which, are inherently uncertain and beyond management’s control.

Forward-looking statements contained in this Form 10-Q may include, but are not limited to, information regarding our estimates for catastrophes and weather-related losses (herein referred as “CAT losses”), measurements of potential losses in the fair market value of our investments, our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, the outcome of our strategic initiatives, our expectations regarding pricing, and other market and economic conditions including inflation, our growth prospects, and valuations of the potential impact of movements in interest rates, equity securities’ prices, and foreign currency exchange rates.

Forward-looking statements only reflect our expectations and are not guarantees of performance. These statements involve risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual events or results to differ materially from those indicated in such statements. We believe that these factors include, but are not limited to:

•a downgrade or withdrawal of our A.M. Best ratings;

•any suspension or revocation of any of our licenses;

•losses from catastrophes and other major events;

•the loss of significant brokers; and

•those described under “Item 1A, Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended December 31,2023, as filed with the SEC on March 5, 2024 (“2023 Form 10-K”), which is accessible on the SEC’s website at www.sec.gov.

We undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only to the dates they were made.

We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding underwriting or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

Item 1. FINANCIAL STATEMENTS

GREENLIGHT CAPITAL RE, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2024 (unaudited) and December 31, 2023

(expressed in thousands of U.S. dollars, except per share and share amounts)


	June 30, 2024		December 31, 2023
Assets
Investments
Investment in related party investment fund, at fair value	$	351,468	$	258,890
Other investments	73,159		73,293
Total investments	424,627		332,183
Cash and cash equivalents	52,240		51,082
Restricted cash and cash equivalents	561,930		604,648
Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854)	686,743		619,401
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $701 and 2023: $487)	58,647		25,687
Deferred acquisition costs	83,305		79,956
Unearned premiums ceded	28,184		17,261
Other assets	4,272		5,089
Total assets	$	1,899,948	$	1,735,307
Liabilities and equity
Liabilities
Loss and loss adjustment expense reserves	$	752,757	$	661,554
Unearned premium reserves	349,015		306,310
Reinsurance balances payable	76,253		68,983
Funds withheld	18,266		17,289
Other liabilities	8,042		11,795
Debt	61,595		73,281
Total liabilities	1,265,928		1,139,212
Commitments and Contingencies (Note 15)
Shareholders' equity
Preferred share capital (par value $0.10; none issued)	—		—
Ordinary share capital (par value $0.10; issued and outstanding, 35,321,144) (2023: par value $0.10; issued and outstanding, 35,336,732)	3,532		3,534
Additional paid-in capital	487,462		484,532
Retained earnings	143,026		108,029
Total shareholders' equity	634,020		596,095
Total liabilities and equity	$	1,899,948	$	1,735,307

The accompanying Notes to the Condensed Consolidated Financial Statements are an

integral part of the Condensed Consolidated Financial Statements.

Return to table of contents

GREENLIGHT CAPITAL RE, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

For the three and six months ended June 30, 2024 and 2023

(expressed in thousands of U.S. dollars, except per share and share amounts)


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Revenues
Gross premiums written	$	168,975	$	154,943	$	386,233	$	341,398
Gross premiums ceded	(14,832)		(9,739)		(38,013)		(20,951)
Net premiums written	154,143		145,204		348,220		320,447
Change in net unearned premium reserves	4,255		(5,261)		(28,286)		(37,855)
Net premiums earned	158,398		139,943		319,934		282,592
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3)	4,330		32,782		22,578		29,644
Net investment income	8,224		9,369		16,367		17,747
Foreign exchange gains (losses)	(932)		4,729		(2,581)		9,660
Other income, net	4,843		2,866		9,878		5,032
Total revenues	174,863		189,689		366,176		344,675
Expenses
Net loss and loss adjustment expenses incurred	102,033		90,504		211,359		187,229
Acquisition costs	50,454		38,293		92,064		79,769
General and administrative expenses	10,517		10,025		21,231		19,961
Deposit interest expense	1,886		235		2,762		367
Interest expense	1,560		744		2,809		1,520
Total expenses	166,450		139,801		330,225		288,846
Income before income tax	8,413		49,888		35,951		55,829
Income tax expense	(435)		(28)		(954)		(82)
Net income	$	7,978	$	49,860	$	34,997	$	55,747

Earnings (loss) per share ("EPS"):
Basic	$	0.23	$	1.46	$	1.02	$	1.64
Diluted	$	0.23	$	1.32	$	1.01	$	1.49
Weighted average number of ordinary shares used in the determination of EPS:
Basic	34,238,863		34,070,818		34,255,454		34,065,066
Diluted	34,699,182		38,267,137		34,679,325		38,322,921

The accompanying Notes to the Condensed Consolidated Financial Statements are an

integral part of the Condensed Consolidated Financial Statements.

Return to table of contents

GREENLIGHT CAPITAL RE, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(UNAUDITED)

For the three and six months ended June 30, 2024 and 2023

(expressed in thousands of U.S. dollars)


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Ordinary share capital
Balance - beginning of period	$	3,532	$	3,526	$	3,534	$	3,482
Issue of ordinary shares, net of forfeitures	—		1		(2)		45

Balance - end of period	3,532		3,527		3,532		3,527
Additional paid-in capital
Balance - beginning of period	485,878		479,429		484,532		478,439

Share-based compensation expense	1,584		1,219		2,930		2,209
Balance - end of period	487,462		480,648		487,462		480,648
Retained earnings
Balance - beginning of period	135,048		27,086		108,029		21,199
Net income	7,978		49,860		34,997		55,747
Balance - end of period	143,026		76,946		143,026		76,946
Total shareholders' equity	$	634,020	$	561,121	$	634,020	$	561,121

The accompanying Notes to the Condensed Consolidated Financial Statements are an

integral part of the Condensed Consolidated Financial Statements.

Return to table of contents

GREENLIGHT CAPITAL RE, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

For the six months ended June 30, 2024 and 2023

(expressed in thousands of U.S. dollars)


	Six months ended June 30
	2024		2023
Cash flows from operating activities
Net income	$	34,997	$	55,747
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities:
Income from investments in related party investment fund	(22,578)		(29,644)
Net realized gain on repurchases of convertible senior notes payable	—		(265)
Net realized and unrealized losses (gains) on other investments	324		(256)
Net realized and unrealized losses (gains) on derivatives	(565)		—
Current expected credit losses (gains) recognized on reinsurance assets	225		500
Share-based compensation expense	2,928		2,254
Accretion of debt offering costs and change in interest accruals	190		(59)

Net change in:
Reinsurance balances receivable	(67,353)		(111,672)
Loss and loss adjustment expenses recoverable	(33,174)		(8,316)
Deferred acquisition costs	(3,349)		(626)
Unearned premiums ceded	(10,923)		(1,074)
Loss and loss adjustment expense reserves	91,203		65,633
Unearned premium reserves	42,705		30,234
Reinsurance balances payable	7,270		4,399
Funds withheld	977		(6,302)
Other items, net	(2,208)		13
Net cash provided by (used in) operating activities	40,669		566
Cash flows from investing activities
Proceeds from redemptions of investment in Solasglas	—		37,997
Contributions to investment in Solasglas	(70,000)		(47,001)
Purchases of other investments	(414)		(4,045)
Proceeds on disposal of other investments	168		6,000

Net cash provided by (used in) investing activities	(70,246)		(7,049)
Cash flows from financing activities

Repayment of term loans	(11,876)		—

Repurchases of convertible senior notes payable	—		(17,085)

Net cash used in financing activities	(11,876)		(17,085)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(107)		351
Decrease in cash, cash equivalents and restricted cash	(41,560)		(23,217)
Cash, cash equivalents and restricted cash at beginning of the period	655,730		706,548
Cash, cash equivalents and restricted cash at end of the period	$	614,170	$	683,331
Supplementary information
Interest paid in cash	$	3,315	$	1,578
Income tax paid (refund received) in cash	153		21

The accompanying Notes to the Condensed Consolidated Financial Statements are an

integral part of the Condensed Consolidated Financial Statements.

Return to table of contents

GREENLIGHT CAPITAL RE, LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

June 30, 2024

1. ORGANIZATION AND BASIS OF PRESENTATION

Organization

Greenlight Capital Re, Ltd. (“GLRE” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

Basis of Presentation

These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2023 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation.

In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year.

Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars.

Reclassifications

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.

2. SIGNIFICANT ACCOUNTING POLICIES

There were no material changes to the Company’s significant accounting policies subsequent to its 2023 Form 10-K.

Recently Issued Accounting Standards Not Yet Adopted

On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted.

Return to table of contents

On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements.

As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.

3. INVESTMENT IN RELATED PARTY INVESTMENT FUND

For the three and six months ended June 30, 2024, there was no change to the Company’s agreement with Solasglas Investments, LP (“Solasglas”). Effective August 1, 2024, the parties amended the agreement to revise the Investment Cap from 60% to 70% (as defined in Note 3 of the 2023 Form 10-K).

The Company’s maximum exposure to loss relating to Solasglas is limited to GLRE's share of Partners’ capital in Solasglas. At June 30, 2024, GLRE’s share of Partners’ capital in Solasglas was $351.5 million (December 31, 2023: $258.9 million), representing 76.3% (December 31, 2023: 72.7%) of Solasglas’ total net assets. DME II held the remaining 23.7% (December 31, 2023: 27.3%) of Solasglas’ total net assets.

The Company’s share of the net increase in Partner’s capital for the three and six months ended June 30, 2024 was $4.3 million and $22.6 million, respectively, (three and six months ended June 30, 2023: $32.8 million and $29.6 million, respectively), as shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP


	June 30, 2024		December 31, 2023
Assets
Investments, at fair value	$	401,510	$	453,358
Derivative contracts, at fair value	11,244		11,167
Due from brokers	169,898		121,754
Cash and cash equivalents	53,460		—
Interest and dividends receivable	195		1,143
Total assets	636,307		587,422

Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value	(162,984)		(197,571)
Derivative contracts, at fair value	(11,147)		(12,917)
Capital withdrawals payable	—		(1,000)
Due to brokers	—		(17,398)
Interest and dividends payable	(1,404)		(2,315)
Accrued expenses and other liabilities	(164)		(247)
Total liabilities	(175,699)		(231,448)

Partners' capital	$	460,608	$	355,974

GLRE’s share of Partners' capital	$	351,468	$	258,890

Return to table of contents

Summarized Statements of Operations of Solasglas Investments, LP


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Investment income
Dividend income (net of withholding taxes)	$	941	$	724	$	1,772	$	1,351
Interest income	2,148		2,076		6,500		3,892
Total Investment income	3,089		2,800		8,272		5,243

Expenses
Management fee	(1,408)		(1,163)		(2,731)		(2,231)
Interest	(736)		(1,579)		(2,070)		(3,007)
Dividends	(731)		(793)		(1,435)		(1,212)
Professional fees and other	(335)		(607)		(659)		(889)
Total expenses	(3,210)		(4,142)		(6,895)		(7,339)

Net investment income (loss)	(121)		(1,342)		1,377		(2,096)

Realized and change in unrealized gains (losses)
Net realized gain (loss)	20,085		(845)		63,030		(2,605)
Net change in unrealized appreciation (depreciation)	(13,138)		54,825		(29,383)		53,792
Net gain (loss) on investment transactions	6,947		53,980		33,647		51,187

Net increase (decrease) in Partners' capital (1)	$	6,826	$	52,638	$	35,024	$	49,091

GLRE’s share of the increase (decrease) in Partners' capital	$	4,330	$	32,782	$	22,578	$	29,644

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Management fees	$	1,408	$	1,163	$	2,731	$	2,231
Performance allocation	481		$	3,294	2,509		3,294
Total	$	1,889	$	4,457	$	5,240	$	5,525

4. OTHER INVESTMENTS

At June 30, 2024, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	27,170	$	49,902	$	(5,206)	$	—	$	71,866
Debt and convertible debt securities	2,713		—		(1,510)		90		1,293

Total other investments	$	29,883	$	49,902	$	(6,716)	$	90	$	73,159

Return to table of contents

At December 31, 2023, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	28,470	$	49,424	$	(6,737)	$	—	$	71,157
Debt and convertible debt securities	2,499		—		(499)		136		2,136

Total other investments	$	30,969	$	49,424	$	(7,236)	$	136	$	73,293

The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at June 30, 2024 and 2023, and the related adjustments recorded during the periods then ended.


	Six months ended June 30
	2024		2023
Carrying value (1)	$	71,866	$	65,904
Upward carrying value changes (2)	$	501	$	506
Downward carrying value changes and impairment (3)	$	(114)	$	(250)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.

(2) The cumulative upward carrying value changes from inception to June 30, 2024, totaled $50.9 million.

(3) The cumulative downward carrying value changes and impairments from inception to June 30, 2024, totaled $2.8 million.

Net investment income

The following table summarizes the change in unrealized gains (losses) and the realized gains (losses) for the Company’s other investments, which are included in “Net investment income” in the condensed consolidated statements of operations (see Note 13):


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross realized gains	$	—	$	—	$	—	$	—
Gross realized losses	—		—		(1,332)		(800)
Net realized gains (losses)	$	—	$	—	$	(1,332)	$	(800)
Change in unrealized gains	89		506		1,008		1,056
Net realized and unrealized gains (losses) on other investments	$	89	$	506	$	(324)	$	256

During the six months ended June 30, 2024, the Company collected $0.2 million of liquidation proceeds relating to a private investment which was previously fully impaired, resulting in a gross realized loss of $1.3 million offset by a corresponding reduction in unrealized losses of $1.5 million.

During the three and six months ended June 30, 2023, the Company realized a loss of $nil and $0.8 million, respectively, and a corresponding reversal of unrealized loss relating to an investment which was previously fully impaired at December 31, 2022, resulting in no impact to the Company’s net income (loss).

Return to table of contents

5. RESTRICTED CASH AND CASH EQUIVALENTS

The following table shows the breakdown of the Company’s restricted cash and cash equivalents, along with a reconciliation of the total cash, cash equivalents, and restricted cash reported in the condensed consolidated statements of cash flows:


	June 30, 2024		December 31, 2023
Restricted cash and cash equivalents:
Cash securing trust accounts	$	274,275	$	300,152
Cash securing letters of credit issued	274,048		291,456
Cash securing Loan Facility	10,000		10,000
Other	3,607		3,040
Total restricted cash and cash equivalents	561,930		604,648
Cash and cash equivalents	52,240		51,082
Total cash, cash equivalents, and restricted cash	$	614,170	$	655,730

Where the Company operates as a non-admitted carrier in certain foreign jurisdictions, regulatory trust accounts and letters of credit are issued to cedents. Additionally, the Company has provided cash collateral for the Loan Facility (see Note 9).

6. FAIR VALUE MEASUREMENTS

Assets measured at fair value on a nonrecurring basis

At June 30, 2024 and December 31, 2023, the Company held $61.8 million and $61.3 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. At June 30, 2024, the Company held $10.0 million (2023: $9.9 million) of private investments and unlisted equities measured at cost. The Company classifies these investments as Level 3 within the fair value hierarchy.

The following table summarizes the periods between the most recent fair value measurement dates and June 30, 2024, for the private and unlisted equities measured at fair value on a nonrecurring basis:


	Less than 6 months		6 to 12 months		Over 1 year		Total
Fair values measured on a nonrecurring basis	$	1,423	$	26,338	$	34,086	$	61,847

Assets measured at fair value on a recurring basis

Derivative financial instruments

The Company uses interest rate swaps in connection with its risk management activities to hedge 50% of the interest rate risk relating to the outstanding Term Loans (see Note 9). The interest rate swaps are carried at fair value and are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors. Accordingly, the interest rates swaps are classified as Level 2 within the fair value hierarchy. These derivative instruments are not designated as accounting hedges under U.S. GAAP.

For the three and six months ended June 30, 2024, the Company recognized a reduction in unrealized loss of $0.1 million and $0.6 million, respectively, for the above derivatives to a nominal value at June 30, 2024, which is included in other liabilities in the condensed consolidated balance sheets, in interest expense in the condensed consolidated statements of operations, and in “net change in unrealized gains and losses on investments and derivatives” in the condensed consolidated statements of cash flows. There were no derivative financial instruments for the three and six months ended June 30, 2023.

Return to table of contents

Financial Instruments Disclosed, But Not Carried, at Fair Value

At June 30, 2024, the carrying value of debt and convertible debt securities within “Other Investments” (see Note 4) and the Term Loans approximates their fair values. The Company classifies these financial instruments as Level 2 within the fair value hierarchy.

7. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:


	June 30, 2024		December 31, 2023
Case reserves	$	210,802	$	189,050
IBNR	541,955		472,504
Total	$	752,757	$	661,554

Reserve Roll-forward

The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:


Consolidated	Six months ended June 30
	2024		2023
Gross balance at January 1	$	661,554	$	555,468
Less: Losses recoverable	(25,687)		(13,239)
Net balance at January 1	635,867		542,229
Incurred losses related to:
Current year	206,647		173,428
Prior years	4,712		13,801
Total incurred	211,359		187,229
Paid losses related to:
Current year	(20,677)		(22,428)
Prior years	(129,716)		(114,056)
Total paid	(150,393)		(136,484)
Foreign currency revaluation	(2,723)		6,572
Net balance at June 30	694,110		599,546
Add: Losses recoverable (see Note 8)	58,647		21,555
Gross balance at June 30	$	752,757	$	621,101

Estimates for Significant Catastrophe Events

At June 30, 2024, the Company’s net reserves for losses and loss expenses include estimated amounts for several catastrophe and weather-related events (“CAT loss”). The magnitude and volume of losses arising from these events is inherently uncertain and, consequently, actual losses for these events may ultimately differ, potentially materially, from current estimates.

During the six months ended June 30, 2024, the Company recognized total CAT loss, net of reinsurance, of $35.2 million. Current year CAT loss events were $25.7 million, driven mainly by the Baltimore bridge collapse, the U.S. tornados (including severe convective storms), satellite failures, and a Mexican state-owned oil platform fire. Additionally, the Company incurred $9.4 million of net adverse prior year CAT loss development relating primarily to severe weather affecting U.S. homeowners’ property coverage (2021-2023 underwriting years).

During the six months ended June 30, 2023, the Company recognized total CAT loss, net of reinsurance, of $19.6 million. Current year CAT loss events were $16.4 million, driven mainly by the Turkey earthquake, New Zealand Cyclone

Return to table of contents

Gabrielle and the U.S. tornados, coupled with $3.2 million net adverse prior year CAT loss development mainly relating to the 2022 Winter Storm Elliott.

Prior Year Reserve Development

During the six months ended June 30, 2024, the Company experienced $4.7 million in net adverse development on prior year loss and LAE reserves. This was composed of $19.5 million of reserve strengthening predominantly for the above prior year CAT loss events, coupled with additional losses reported on general liability contracts (mostly 2014-2017 underwriting years) and legacy quota share workers’ compensation treaties (mostly 2017-2021 underwriting years) due to current economic and social inflation trends. The reserve increases were partially offset by $14.8 million favorable loss development predominantly from mortgage contracts (various underwriting years), multi-line commercial treaties (mostly 2020 underwriting year), Funds at Lloyd’s (“FAL”) (2023 underwriting year), and other specialty business (mostly 2020-2022 underwriting years).

During the six months ended June 30, 2023, the Company experienced $13.8 million in net adverse development on prior year loss and LAE reserves. This was comprised of $21.5 million of reserve strengthening predominantly on casualty contracts (mostly 2018, 2019 and 2021 underwriting years) and property contracts (mostly 2020 and 2021 underwriting years) due to current economic and social inflation trends, coupled with adverse CAT loss development on U.S. homeowners’ property business relating to Winter Storm Elliott (2022 underwriting year). This was partially offset by $7.7 million better than expected loss emergence predominantly from other property catastrophe events (mostly 2019, 2021 and 2022 underwriting years).

8. RETROCESSION

The following table provides a breakdown of ceded reinsurance:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross ceded premiums	$	14,832	$	9,739	$	38,013	$	20,951
Earned ceded premiums	$	11,849	$	11,296	$	27,091	$	19,877
Loss and loss adjustment expenses ceded	$	14,773	$	9,537	$	37,849	$	15,708

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. The following table shows a breakdown of losses recoverable on a gross and net of collateral basis:


	June 30, 2024				December 31, 2023
	Gross		Net of Collateral(1)		Gross		Net of Collateral(1)
A- or better by A.M. Best	$	33,288	$	33,288	$	8,767	$	8,767
Not rated	26,059		8,816		17,407		2,432
Total before provision	59,347		$	42,104	$	26,174	$	11,199
Provision for credit losses	(700)				(487)
Total loss and loss adjustment expenses recoverable, net	$	58,647			$	25,687

(1) Collateral is in the form of cash, letters of credit, funds withheld, and/or cash collateral held in trust accounts. This excludes any excess collateral in order to disclose the aggregate net exposure for each retrocessionaire.

At June 30, 2024, we had 3 reinsurers (December 31, 2023: 3) that accounted for 10% or more of the total loss and loss adjustment expenses recoverable, net, for an aggregate gross amount of $42.3 million (December 31, 2023: $20.4 million).

Return to table of contents

9. DEBT AND CREDIT FACILITIES

Debt Obligations

The following table summarizes the Company’s outstanding debt obligations.


	June 30, 2024		December 31, 2023
Term loans	$	62,188	$	74,062
Accrued interest payable	38		—
Less: deferred financing costs	(631)		(781)
Total debt	$	61,595	$	73,281

During the six months ended June 30, 2024, the Company partially repaid $11.9 million of the outstanding Term loans.

Credit Facilities

At June 30, 2024, the Company had the following letter of credit (“LOC”) facilities:


	Capacity		LOCs issued		Termination Date
Citibank Europe plc ("Citi LOC")1	$	289,000	$	231,665	August 20, 2024
CIBC Bank USA ("CIBC LOC")	200,000		42,338		December 21, 2024
	$	489,000	$	274,003

1) Includes $14 million of uncommitted capacity.

The above LOCs issued are cash collateralized (see Note 5). The LOC facilities are subject to various customary affirmative, negative and financial covenants. At June 30, 2024, the Company was in compliance with all LOC facilities covenants.

On April 12, 2024, the Company received written notice from Citibank Europe plc (“Citi”) of its decision to terminate the $275 million committed capacity under the Citi LOC agreement, with an effective date of August 20, 2024. However, Citi informed the Company that it intends to continue providing the Citi LOC on an uncommitted basis for the foreseeable future following the termination date.

10. SHARE CAPITAL

Ordinary Shares

The following table is a summary of changes in ordinary shares issued and outstanding for the six months ended June 30:


	2024	2023
	Ordinary	Class A	Class B
Balance – beginning of period	35,336,732	28,569,346	6,254,715
Issue of shares, net of forfeitures	(15,588)	447,952	—



Balance – end of period	35,321,144	29,017,298	6,254,715

The Company’s authorized share capital is 125,000,000 ordinary shares, par value of $0.10 per share.

On July 25, 2023, at the Company’s Annual General Meeting the shareholders approved the re-designation of Class B ordinary shares as Class A ordinary shares, and then reclassified Class A ordinary shares as “ordinary shares”, resulting in the elimination of the dual-class share structure.

At June 30, 2024, the Company has an effective Form S-3 registration statement on file with the SEC for an aggregate principal amount of $200.0 million in securities.

Share Repurchase Plan

On May 3, 2024, the Board of Directors re-approved the share repurchase plan, until June 30, 2025, authorizing the Company to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market,

Return to table of contents

through privately negotiated transactions or Rule 10b5-1 stock trading plans. Any shares repurchased are canceled immediately upon repurchase. For the six months ended June 30, 2024 and 2023, there was no repurchase of ordinary shares.

Preferred Shares

The Company’s authorized share capital also consists of 50,000,000 preference shares with a par value of $0.10 each. At June 30, 2024, the Company has no issued and outstanding preferred shares.

11. SHARE-BASED COMPENSATION

Refer to Note 11 of the Company’s audited consolidated financial statements of its 2023 Form 10-K for a summary of the Company’s 2023 Incentive Plan, including the definition of performance-based and service-based stock awards.

Employee and Director Restricted Shares

The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the six months ended June 30, 2024 and 2023:


	Performance Restricted Shares			Service Restricted Shares
	Number of non-vested restricted shares	Weighted average grant date fair value		Number of non-vested restricted shares	Weighted average grant date fair value
Balance at December 31, 2022	794,362	$	7.62	832,896	$	7.76
Granted	357,766	9.85		177,563	9.84
Vested	—	—		(256,243)	6.75
Forfeited	(109,105)	9.37		(55,967)	8.43
Balance at June 30, 2023	1,043,023	$	8.20	698,249	$	8.60

Balance at December 31, 2023	1,042,688	$	9.94	419,604	$	9.18
Granted	—	—		—	—
Vested	—	—		(217,522)	8.78
Forfeited	(89,945)	10.84		—	—
Balance at June 30, 2024	952,743	$	9.86	202,082	$	9.61

At June 30, 2024, 2,914,198 (December 31, 2023: 3,296,771) ordinary shares remained available for future issuance under the Company’s 2023 Incentive Plan.

There was no grant of RSs during the six months ended June 30, 2024 (2023: 535,329). For the six months ended June 30, 2024, the total fair value of Service RSs vested was $1.9 million (2023: $1.7 million).

Return to table of contents

Employee Restricted Stock Units

The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the six months ended June 30, 2024 and 2023:


	Performance RSUs			Service RSUs
	Number of non-vested RSUs	Weighted average grant date fair value		Number of non-vested RSUs	Weighted average grant date fair value
Balance at December 31, 2022	105,008	$	6.82	172,952	$	7.58
Granted	71,121	9.85		42,811	9.85
Vested	—	—		(77,695)	6.74
Forfeited	—	—		(1,788)	7.82
Balance at June 30, 2023	176,129	$	8.04	136,280	$	8.76

Balance at December 31, 2023	154,445	$	8.03	110,425	$	8.78
Granted	258,148	11.85		124,425	11.85
Vested	—	—		(74,357)	8.84
Forfeited	—	—		—	—
Balance at June 30, 2024	412,593	$	10.42	160,493	$	11.14

For the awards granted during the six months ended June 30, 2024, the Service RSUs vest evenly over three years on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of a three-year performance period within a range of 50% and 200% of the awarded Performance RSUs, with a target of 100%.

For the six months ended June 30, 2024, the total fair value of Service RSUs vested was $0.7 million (2023: $0.5 million).

Employee and Director Stock Options

During the six months ended June 30, 2024, 250,000 ordinary share purchase options were granted to the Company’s CEO, pursuant to his employment contract. These options vest 50,000 annually and expire in 10 years from the grant date. The grant date fair value of these options was $4.31 per share, based on the Black-Scholes option pricing model. The following inputs were used in this pricing model:



Expected volatility	36.4		%
Expected term (in years)	5
Expected dividend yield	—		%
Risk-free interest rate	3.9		%
Stock price at grant date	$	11.20

Stock Compensation Expense

For the six months ended June 30, 2024 and 2023, the Company recorded $2.9 million and $2.3 million of total stock compensation expense (net of forfeitures), respectively. The stock compensation expense is included in “General and administrative expenses” in the condensed consolidated statements of operations. Forfeiture recoveries were immaterial for both periods.

Return to table of contents

12. EARNINGS PER SHARE

The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and six months ended June 30, 2024 and 2023:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Numerator for EPS
Net income - basic	$	7,978	$	49,860	$	34,997	$	55,747
Add: interest on convertible notes	—		744		—		1,520
Less: gain on repurchase of convertible notes	—		—		—		(265)
Net income - diluted	$	7,978	$	50,604	$	34,997	$	57,002

Denominator for EPS
Weighted average shares outstanding - basic	34,238,863		34,070,818		34,255,454		34,065,066
Effect of dilutive employee and director share-based awards	460,319		580,494		423,871		534,958
Shares potentially issuable in connection with convertible notes	—		3,615,825		—		3,722,897
Weighted average shares outstanding - diluted	34,699,182		38,267,137		34,679,325		38,322,921
Anti-dilutive stock options outstanding	902,140		690,337		902,140		690,337


EPS:
Basic	$	0.23	$	1.46	$	1.02	$	1.64
Diluted	$	0.23	$	1.32	$	1.01	$	1.49

13. NET INVESTMENT INCOME

The following table provides a breakdown of net investment income:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Interest and dividend income, net of withholding taxes and other expenses	$	8,135	$	8,863	$	16,691	$	17,491
Net realized and unrealized gains on other investments (see Note 4)	89		506		(324)		256
Net investment-related income	8,224		9,369		16,367		17,747
Share of Solasglas' net income (see Note 3)	4,330		32,782		22,578		29,644
Total investment income	$	12,554	$	42,151	$	38,945	$	47,391

14. RELATED PARTY TRANSACTIONS

Investment Advisory Agreement

There has been no change to the Company’s agreement with Solasglas as described in its 2023 Form 10-K. Refer to Note 3 for a breakdown of management fees and performance fees for the six months ended June 30, 2024 and 2023.

Return to table of contents

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At June 30, 2024, Solasglas, along with certain affiliates of DME Advisors, collectively owned 25.2% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in Solasglas. At June 30, 2024, Solasglas held 1.8 million shares of GRBK. Subsequent to June 30, 2024, Solasglas reduced its exposure to GRBK and as of July 31, 2024 held 1.3 million shares of GRBK.

Service Agreement

The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party.

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the Solasglas LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.

15. COMMITMENTS AND CONTINGENCIES

a) Concentration of Credit Risk

Cash and cash equivalents

The Company monitors its concentration of credit risk with financial institutions and limits acceptable counterparties based on current rating, outlook and other relevant factors.

Investments

The Company’s credit risk exposure to private debt and convertible debt securities within its “Other investments” are immaterial (see Note 4).

Reinsurance balances receivable, net

The following table shows the breakdown of reinsurance balances receivable:

Return to table of contents


	June 30, 2024				December 31, 2023
	Amount		%		Amount		%
Premiums receivable	$	260,801	38.0	%	$	186,940	30.2	%

Funds withheld:
Funds held by cedants	48,790		7.1	%	50,075		8.1	%
Premiums held by Lloyds' syndicates	264,685		38.5	%	264,278		42.7	%
Funds at Lloyd’s	110,624		16.1	%	115,772		18.6	%

Profit commission receivable	2,708		0.4	%	2,302		0.4	%

Deposit assets	—		—	%	888		0.1	%
Total before provision	687,608		100.1	%	620,255		100.1	%
Provision for expected credit losses	(865)		(0.1)	%	(854)		(0.1)	%
Reinsurance balances receivable, net	$	686,743	100.0	%	$	619,401	100.0	%

The Company has posted deposits at Lloyd’s to support underwriting capacity for certain syndicates, including Syndicate 3456. Lloyd’s has a credit rating of “A” (Excellent) from A.M. Best.

Premiums receivable includes a significant portion of estimated premiums not yet due. Brokers and other intermediaries are responsible for collecting premiums from customers on the Company’s behalf. The Company monitors its concentration of credit risks from brokers. The diversity in the Company’s client base limits credit risk associated with premiums receivable and funds (premiums) held by cedents. Further, under the reinsurance contracts the Company has contractual rights to offset premium balances receivable and funds held by cedants against corresponding payments for losses and loss expenses.

Loss and loss adjustment expenses recoverable, net

The Company regularly evaluates its net credit exposure to the retrocessionaires and their abilities to honor their respective obligations. See Note 8 for analysis of concentration of credit risk relating to retrocessionaires.

b) Lease Obligations

There was no material change to the Company’s operating lease agreements subsequent to its 2023 Form 10-K.

c) Litigation

From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.

Return to table of contents

16. SEGMENT REPORTING

The Company has one operating segment: Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property
Commercial	$	12,070	7.1	%	$	14,440	9.3	%	$	30,236	7.8	%	$	29,131	8.5	%
Motor	93		0.1		352		0.2		155		—		584		0.2
Personal	10,614		6.3		16,368		10.6		17,562		4.5		32,005		9.4
Total Property	22,777		13.5		31,160		20.1		47,953		12.3		61,720		18.1

Casualty
General Liability	33,741		20.0		27,517		17.8		55,398		14.3		48,076		14.1
Motor Liability	8,638		5.1		2,707		1.7		14,656		3.8		8,306		2.4
Professional Liability	(448)		(0.3)		2,625		1.7		119		—		6,272		1.8
Workers' Compensation	(40)		—		3,899		2.5		3,380		0.9		7,058		2.1
Multi-line	38,314		22.7		51,724		33.4		113,441		29.4		105,884		31.0
Total Casualty	80,205		47.5		88,472		57.1		186,994		48.4		175,596		51.4

Other
Accident & Health	2,947		1.7		2,013		1.3		3,878		1.0		4,489		1.3
Financial	17,945		10.6		8,850		5.7		38,144		9.9		31,347		9.2
Marine	10,879		6.4		7,854		5.1		30,442		7.9		19,994		5.9
Other Specialty	34,222		20.3		16,594		10.7		78,822		20.5		48,252		14.1
Total Other	65,993		39.1		35,311		22.8		151,286		39.3		104,082		30.5
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

Gross Premiums Written by Geographic Area of Risks Insured


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
U.S. and Caribbean	$	61,786	36.6	%	$	59,588	38.5	%	$	119,160	30.9	%	$	129,440	37.9	%
Worldwide (1)	90,153		53.4		75,131		48.5		234,462		60.7		181,393		53.1
Europe	3,792		2.2		3,641		2.3		8,280		2.1		7,068		2.1
Asia	13,244		7.8		16,583		10.7		24,331		6.3		23,497		6.9
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.

Return to table of contents

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References to “we,” “us,” “our,” “our company,” or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and its wholly-owned subsidiaries unless the context dictates otherwise.

The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our 2023 Form 10-K.

The following is management’s discussion and analysis (“MD&A”) of our results of operations for the three and six months ended June 30, 2024 and 2023 and the Company’s financial condition at June 30, 2024 and December 31, 2023 (herein referred as “Q2 2024 Financials”).

All amounts are reported in U.S. dollars, unless otherwise noted. Tabular dollars are presented in thousands, with the exception of per share amounts or as otherwise noted.

Page


Overview			23
Business Overview			23
Outlook and Trends			23
Key Financial Measures and Non-GAAP Measures			24
Consolidated Results of Operations			26
Financial Condition			36
Liquidity and Capital Resources			39
Liquidity			39
Capital Resources			39
Critical Accounting Estimates			40
Recent Accounting Pronouncements			40

Return to table of contents

Overview

Business Overview

We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with an underwriting and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces.

For the second quarter of 2024 (“Q2 2024”) we earned a net income of $8.0 million, a decrease of $41.9 million over the same period in the prior year, principally due to the lower return from our investment in Solasglas and to a lesser extent lower underwriting profits driven by higher CAT losses.

The following is a summary of our financial performance for Q2 2024, compared to the same quarter in 2023 (“Q2 2023”):

•Gross premiums written was $169.0 million, an increase of 9.1%;

•Net premiums earned was $158.4 million, an increase of 13.2%;

•Net underwriting income (1) was $0.3 million, compared to $5.4 million;

•Total CAT losses, net of reinsurance, were $17.9 million, compared to $9.3 million;

•Total investment income was $12.6 million, a decrease of 70.2% (including 1.2% net return from our investment in Solasglas, compared to net return of 10.9%); and

•Diluted EPS was $0.23, compared to $1.32.

Fully diluted book value per share(1) was $17.65 at June 30, 2024, an increase of 5.4% since December 31, 2023.

(1) See “Key Financial Measures and Non-GAAP Measures” section of this MD&A.

Outlook and Trends

The 2024 mid-year renewals have been characterized by a healthy balance of supply and demand of reinsurance capacity. Reinsurance terms and conditions are retaining discipline across a majority of classes, most notably with respect to property excess of loss attachment points. We continue to view the terms and conditions available in the property and specialty market as attractive for growth.

As we approach the peak months of North Atlantic hurricane season, the industry’s attention is drawn to the record set in early July by Hurricane Beryl for the earliest category 5 storm to form in the North Atlantic. Another key focus in the industry is the degree of additional reserve strengthening that may emerge in casualty classes throughout the remainder of the year.

It is likely that terms and conditions in the reinsurance market will be highly dependent on the progression of the above factors throughout the remainder of 2024.

Return to table of contents

Key Financial Measures and Non-GAAP Measures

There have been no changes to our key financial measures, including non-GAAP financial measures, as described in the MD&A of our 2023 Form 10-K.

Fully Diluted Book Value Per Share

The following table presents a reconciliation of the fully diluted book value per share to basic book value per share (the most directly comparable U.S. GAAP financial measure):


	June 30, 2024			March 31, 2024			December 31, 2023			September 30, 2023			June 30, 2023
Numerator for basic and fully diluted book value per share:
Total equity as reported under U.S. GAAP	$	634,020		$	624,458		$	596,095		$	575,865		$	561,121


Denominator for basic and fully diluted book value per share:
Ordinary shares issued and outstanding as reported and denominator for basic book value per share	35,321,144			35,321,144			35,336,732			35,337,407			35,272,013
Add: In-the-money stock options (1) and all outstanding RSUs	594,612			585,334			264,870			312,409			312,409
Denominator for fully diluted book value per share	35,915,756			35,906,478			35,601,602			35,649,816			35,584,422

Basic book value per share	$	17.95		$	17.68		$	16.87		$	16.30		$	15.91
Increase in basic book value per share ($)	$	0.27		$	0.81		$	0.57		$	0.39		$	1.45
Increase in basic book value per share (%)	1.5		%	4.8		%	3.5		%	2.5		%	10.0		%

Fully diluted book value per share	$	17.65		$	17.39		$	16.74		$	16.15		$	15.77
Increase in fully diluted book value per share ($)	$	0.26		$	0.65		$	0.59		$	0.38		$	1.43
Increase in fully diluted book value per share (%)	1.5		%	3.9		%	3.7		%	2.4		%	10.0		%

(1) Assuming net exercise by the grantee.

Return to table of contents

Net Underwriting Income (Loss)

The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis are shown below:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Income before income tax	$	8,413	$	49,888	$	35,951	$	55,829
Add (subtract):
Total investment income	(12,554)		(42,151)		(38,945)		(47,391)
Foreign exchange losses (gains)	932		(4,729)		2,581		(9,660)
Other non-underwriting income	(2,724)		(2,866)		(7,759)		(5,032)
Corporate expenses	4,706		4,557		9,081		10,554
Interest expense	1,560		744		2,809		1,520
Net underwriting income	$	333	$	5,443	$	3,718	$	5,820

Return to table of contents

Consolidated Results of Operations

The table below summarizes our consolidated operating results for the three and six months ended June 30, 2024 and 2023:


	Three months ended June 30						Six months ended June 30
	2024			2023			2024			2023
Underwriting revenue
Gross premiums written	$	168,975		$	154,943		$	386,233		$	341,398
Gross premiums ceded	(14,832)			(9,739)			(38,013)			(20,951)
Net premiums written	154,143			145,204			348,220			320,447
Change in net unearned premium reserves	4,255			(5,261)			(28,286)			(37,855)
Net premiums earned	$	158,398		$	139,943		$	319,934		$	282,592
Underwriting related expenses
Net loss and loss adjustment expenses incurred:
Current year	$	102,722		$	88,740		$	206,647		$	173,428
Prior year (1)	(689)			1,764			4,712			13,801
Net loss and loss adjustment expenses incurred	102,033			90,504			211,359			187,229
Acquisition costs	50,454			38,293			92,064			79,769
Underwriting expenses	5,811			5,468			12,150			9,407
Deposit interest expense (income), net	(233)			235			643			367
Net underwriting income (2)	$	333		$	5,443		$	3,718		$	5,820

Income (loss) from investment in Solasglas	$	4,330		$	32,782		$	22,578		$	29,644
Net investment income	8,224			9,369			16,367			17,747
Total investment income	$	12,554		$	42,151		$	38,945		$	47,391

Corporate expenses	$	4,706		$	4,557		$	9,081		$	10,554
Foreign exchange losses (gains)	932			(4,729)			2,581			(9,660)
Other income, net	(2,724)			(2,866)			(7,759)			(5,032)
Interest expense	1,560			744			2,809			1,520
Income tax expense	435			28			954			82
Net income	$	7,978		$	49,860		$	34,997		$	55,747

Earnings per share:
Basic	$	0.23		$	1.46		$	1.02		$	1.64
Diluted	$	0.23		$	1.32		$	1.01		$	1.49

Underwriting ratios:
Loss ratio - current year	64.8		%	63.4		%	64.6		%	61.4		%
Loss ratio - prior year	(0.4)		%	1.3		%	1.5		%	4.9		%
Loss ratio	64.4		%	64.7		%	66.1		%	66.3		%
Acquisition cost ratio	31.9		%	27.4		%	28.8		%	28.2		%
Composite ratio	96.3		%	92.1		%	94.9		%	94.5		%
Underwriting expense ratio	3.5		%	4.1		%	4.0		%	3.5		%
Combined ratio	99.8		%	96.2		%	98.9		%	98.0		%

Return to table of contents

1 The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs, and deposit interest income and expense, was a loss of $0.4 million and $1.9 million for the three months ended June 30, 2024 and 2023, respectively, and a loss of $5.8 million and $13.9 million for the six months ended June 30, 2024 and 2023, respectively.

2 Net underwriting income is a non-GAAP financial measure. See “ Key Financial Measures and Non-GAAP Measures” above for discussion and reconciliation of non-GAAP financial measures.

The following provides further details on the significant variances for Q2 2024 compared to same quarter in 2023 (“Q2 2023”) and for the six months ended June 30, 2024 (“YTD 2024”) compared to the same period in 2023 (“YTD 2023”).

Overview

Three months ended June 30, 2024

Fully diluted book value per share increased by $0.26 per share, or 1.5%, to $17.65 per share from $17.39 per share at March 31, 2024. Basic book value per share increased by $0.27 per share, or 1.5%, to $17.95 per share from $17.68 per share at March 31, 2024.

Net income was $8.0 million for Q2 2024, compared to net income of $49.9 million reported for Q2 2023.

The developments that most significantly affected our financial performance during Q2 2024, compared to Q2 2023, are summarized below:

•Underwriting income: Decreased by $5.1 million primarily driven by 3.6 percentage points increase in our combined ratio, predominantly due to higher acquisition costs relating to our FAL business, partially offset by improved loss ratio and underwriting expense ratio. While total CAT losses were higher than in Q2 2023, this was offset by improved attritional loss ratio for our underwriting portfolio during the quarter. Current year CAT losses contributed 8.4% to our combined ratio, compared to 7.3% in Q2 2023. For further information on CAT losses and prior year loss development, refer to Note 7 - Loss and Loss Adjustment Expense Reserves of the Q2 2024 Financials.

•Investment income: Decreased by $29.6 million primarily driven by lower income from Solasglas. Our investment in Solasglas reported a gain of $4.3 million during Q2 2024, compared to a gain of $32.8 million during Q2 2023. Solasglas generated a net return of 1.2% for Q2 2024 compared to a net return of 10.9% for Q2 2023; and

•Foreign exchange gains (losses): $0.9 million foreign exchange losses for Q2 2024, compared to $4.7 million foreign exchange gains in Q2 2023, driven mainly by the strengthening of the pound sterling against the U.S. dollar in Q2 2023 whereby there was no significant movement in Q2 2024.

Six months ended June 30, 2024

Fully diluted book value per share increased by $0.91 per share, or 5.4%, to $17.65 per share from $16.74 per share at December 31, 2023. Basic book value per share increased by $1.08 per share, or 6.4%, to $17.95 per share from 16.87 per share at December 31, 2023.

Net income was $35.0 million for YTD 2024, compared to net income of $55.7 million reported for YTD 2023.

The developments that most significantly affected our financial performance during YTD 2024, compared to YTD 2023, are summarized below:

•Underwriting income: Decreased by $2.1 million primarily driven by 0.9 percentage points increase in our combined ratio mainly due to an increase in acquisition costs (same reason as Q2 2024) and an increase in underwriting expenses. While current year CAT losses contributed 8.0 percentage points to our combined ratio, compared to 5.8 percentage points for YTD 2023, the increase was offset by an improved attritional loss ratio for

Return to table of contents

our underwriting portfolio. For further information on CAT losses and prior year loss development, refer to Note 7 - Loss and Loss Adjustment Expense Reserves of the Q2 2024 Financials.

•Investment income: Decreased by $8.4 million primarily driven by lower income from Solasglas. Our investment in Solasglas reported a gain of $22.6 million during YTD 2024, compared to a gain of $29.6 million during the equivalent period in 2023. Solasglas generated a net return of 6.4% for YTD 2024 compared to a net return of 9.7% for YTD 2023 .

•Corporate expense: Decreased by $1.5 million mainly due to non-recurring severance costs included in YTD 2023 and lower outside legal costs following the hiring of our new General Counsel in April 2023.

•Foreign exchange gains (losses): $2.6 million foreign exchange losses for YTD 2024, compared to $9.7 million foreign exchange gains for YTD 2023, driven mainly by the reversal of the pound sterling movement against the U.S. dollar; and

•Other income, net: Increased by $2.7 million due to stronger investment income generated on funds withheld by third party Lloyd’s syndicates, reported on a quarterly lag basis.

Underwriting Results by Segment

The following provides a further discussion of our underwriting results for our Property & Casualty (Re)insurance operating segment for the three and six months ended June 30, 2024 and 2023.

Gross Premiums Written

Details of gross premiums written are provided in the following table:


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property	$	22,777	13.5	%	$	31,160	20.1	%	$	47,953	12.4	%	$	61,720	18.1	%
Casualty	80,205		47.5		88,472		57.1		186,994		48.4		175,596		51.4
Other	65,993		39.1		35,311		22.8		151,286		39.2		104,082		30.5
Total	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

As a result of our underwriting philosophy, the total premiums we write and the mix of premiums between property, casualty, and other business, may vary significantly from period to period depending on the market opportunities we identify.

Our Q2 2024 gross premiums written increased by $14.0 million, or 9.1%, compared to the equivalent 2023 period.

Return to table of contents

The following table provides a further analysis of this overall increase:

Gross Premiums Written

Three months ended June 30, 2024

Increase (decrease)
($ in millions)

% change

Explanation

Property

$(8.4)

(26.9)%

The decrease was driven predominantly by the non-renewal of a U.S. homeowners’ property treaty within Personal class. This was offset partially by growth in the Commercial class driven by new Innovations business. This resulted in a change in business mix for Property, with Commercial and Personal accounting for 53% and 47%, respectively, of total Property compared to 46% and 53%, respectively, for the same quarter in 2023.

Casualty

$(8.3)

(9.3)%

The decrease was driven predominantly from revision to estimated ultimate gross premiums for certain 2023 and 2024 FAL treaties, partially offset by growth experienced by Syndicate 3456, within the Multi-line class.

Additionally, we revised the estimated premiums for certain prior years’ quota share treaties within Professional and Workers’ Compensation classes of business. This reduction in Casualty premiums was partially offset by growth in the General Liability class from 2023 quota share treaties and new business in 2024. Further, Motor Liability premium increased mainly due to new excess of loss treaties.

As a result, the business mix within our Casualty line of business has changed with General Liability, Motor Liability, and Multi-line classes accounting for 42%, 11%, and 48% of total Casualty, respectively, compared to 31%, 3%, and 58% in the same period in 2023.

Other

$30.7

86.9%

The increase was driven predominantly by new business in our Marine and Energy class, including Lloyd’s whole account excess of loss treaties.

Our YTD 2024 gross premiums written increased by $44.8 million, or 13.1%, compared to the equivalent 2023 period.

The following table provides a further analysis of this overall increase:

Gross Premiums Written

Six months ended June 30, 2024

Increase (decrease)
($ in millions)

% change

Explanation

Property

$(13.8)

(22.3)%

Same trends as noted for Q2 2024. This resulted in a change in business mix for Property, with Commercial and Personal accounting for 53% and 47%, respectively, of total Property compared to 46% and 53%, respectively, for the same period in 2023.

Casualty

$11.4

6.5%

The increase was due to growth in the General Liability and Motor Liability classes of business as noted for Q2 2024, coupled with an overall net increase in Multi-Line class, driven mainly by growth in our Syndicate 3456. The growth in Motor Liability class is predominantly from new excess of loss treaties.

The above growth was partially offset by revision to estimated ultimate gross premiums for certain 2023 and 2024 FAL treaties and by lower premiums for Professional and Workers’ Compensation classes of business.

General Liability and Multi-line classes accounted for 30% and 61%, respectively, of total Casualty, compared to 27% and 60%, respectively, in the same period in 2023.

Other

$47.2

45.4%

Same trends as noted for Q2 2024.

Return to table of contents

Premiums Ceded

For Q2 2024, premiums ceded were $14.8 million, or 8.8% of gross premiums written, compared to $9.7 million, or 6.3% of gross premiums written, for the same quarter in 2023. For YTD 2024, premiums ceded were $38.0 million, or 9.8% of gross premiums written, compared to $21.0 million, or 6.1% of gross premiums written, for YTD 2023.

The increase in both periods was primarily due to the purchase of an additional retrocessional coverage to manage our overall exposure to Marine and Energy class in light of recent growth in this class of business and to reinstate certain retro excess of loss treaties in which the full coverage was presumed exhausted primarily from the Baltimore bridge loss event. Additionally, we had an increase in quota share retrocessions for Other Specialty business due to growth from inward premiums.

Net Premiums Written

Details of net premiums written are provided in the following table:


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property	$	16,855	10.9	%	$	26,433	18.2	%	$	38,059	10.9	%	$	52,626	16.4	%
Casualty	77,431		50.2		84,840		58.4		176,881		50.8		172,036		53.7
Other	59,857		38.8		33,931		23.4		133,280		38.3		95,785		29.9
Total	$	154,143	100.0	%	$	145,204	100.0	%	$	348,220	100.0	%	$	320,447	100.0	%

For Q2 2024 and YTD 2024, net premiums written increased by $8.9 million, or 6.2%, and $27.8 million or 8.7%, respectively, compared to the same periods in 2023. The movement in net premiums written resulted from the changes in gross premiums written and ceded during the periods as previously noted.

Net Premiums Earned

Details of net premiums earned are provided in the following table:


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property	$	18,119	11.4	%	$	20,749	14.8	%	$	41,476	13.0	%	$	39,492	14.0	%
Casualty	86,155		54.4		81,446		58.2		180,793		56.5		165,561		58.6
Other	54,124		34.2		37,748		27.0		97,665		30.5		77,539		27.4
Total	$	158,398	100.0	%	$	139,943	100.0	%	$	319,934	100.0	%	$	282,592	100.0	%

Net premiums earned for Q2 2024 and YTD 2024, increased by $18.5 million or 13.2%, and by $37.3 million or 13.2%, respectively, compared to the same periods in 2023. The change in net premiums earned is primarily a function of the amount and timing of net premiums written during the current and prior periods, coupled with the mix of business written in the form of excess of loss versus proportional contracts. For Q2 2024 and YTD 2024, excess of loss treaties accounted for 16% and 15% of the total net premiums earned, respectively, compared to 14% and 13% for Q2 2023 and YTD 2023, respectively.

Return to table of contents

Loss and LAE Incurred, Net

The components of the loss ratio were as follows:


	Three months ended June 30					Six months ended June 30
	2024		2023		Increase / (decrease) in loss ratio points	2024		2023		Increase / (decrease) in loss ratio points
Current accident year loss ratio	64.8	%	63.4	%	1.4	64.6	%	61.4	%	3.2
Prior year reserve development ratio	(0.4)	%	1.3	%	(1.7)	1.5	%	4.9	%	(3.4)
Loss ratio	64.4	%	64.7	%	(0.3)	66.1	%	66.3	%	(0.2)

For Q2 2024 and YTD 2024, our total loss ratio improved by 0.3 and 0.2 percentage points, respectively, compared to the same periods in 2023.

Current accident year loss ratio increased by 1.4 percentage points for Q2 2024, compared to the same quarter in 2023 driven mainly by 1.3 points increase in CAT losses. This increase was driven predominantly by the severe U.S. tornados (including convective storms).

Current accident year loss ratio increased by 3.2 percentage points for YTD 2024, compared to the same period in 2023, driven by 2.2 points increase in CAT loss events, mainly due to the Baltimore bridge loss and the severe U.S. tornados. While we have not renewed a U.S. homeowners’ property program in 2024, we wrote and earned premiums from the 2023 quota share treaty during 2024.

For the current quarter, we had prior year favorable loss development of 0.4%, compared to adverse loss development of 1.3% for the same quarter in 2023. For YTD 2024, our prior year adverse loss development improved by 3.4 percentage points compared to the same period in 2023. Refer to Note 7 for further details on prior year loss development.

Details of net losses incurred by line of business are provided in the following table:


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property	$	21,155	20.7	%	$	21,402	23.6	%	$	33,133	15.7	%	$	38,932	20.8	%
Casualty	58,581		57.3		49,608		54.8		118,598		56.1		110,646		59.1
Other	22,297		22.0		19,494		21.6		59,628		28.2		37,651		20.1
Total	$	102,033	100.0	%	$	90,504	100.0	%	$	211,359	100.0	%	$	187,229	100.0	%

The below table summarizes the loss ratios by line of business:


	Three months ended June 30					Six months ended June 30
	2024		2023		Increase / (decrease) in loss ratio points	2024		2023		Increase / (decrease) in loss ratio points
Property	116.8	%	103.1	%	13.7	79.9	%	98.6	%	(18.7)
Casualty	68.0		60.9		7.1	65.6		66.8		(1.2)
Other	41.2		51.6		(10.4)	61.1		48.6		12.5
Total	64.4	%	64.7	%	(0.3)	66.1	%	66.3	%	(0.2)

Return to table of contents

The following provides further details on the change in Q2 2024 vs. Q2 2023.

Net Losses Incurred

Three months ended June 30, 2024

Increase (decrease)
($ in millions)

Increase / (decrease) in loss ratio points

Property

$(0.2)

13.7

The marginal decrease in losses incurred was driven by the 12.7% decrease in net premiums earned, offset partially by an increase of $0.3 million in current CAT losses mainly from U.S. tornados and to a lesser extent from German floods.

The increase in loss ratio points is driven mainly by the higher attritional and CAT losses from a U.S. homeowners’ property program which was non-renewed in 2024.

Casualty

$9.0

7.1

Driven by the 5.8% increase in net premiums earned, coupled with an increase in prior year adverse loss development, which contributed 7.1 percentage points to the loss ratio. This was predominantly driven by our legacy Multiline and Workers’ Compensation exposures.

Other

$2.8

(10.4)

Driven by the 43.4% increase in net premiums earned, offset partially by favorable prior year loss development, mainly in our Mortgage and Marine and Energy classes of business. This contributed 16.8 percentage points to the reduction in the loss ratio. However, offsetting this benefit, our current attritional loss ratio increased for the Marine class in 2024 compared 2023.

The following provides further details on the change in YTD 2024 vs. YTD 2023.

Net Losses Incurred

Six months ended June 30, 2024

Increase (decrease)
($ in millions)

Increase / (decrease) in loss ratio points

Property

$(5.8)

(18.7)

Despite the 5.0% increase in net premiums earned, the losses incurred and loss ratio decreased predominantly due to the 16.6 percentage points decrease in property-related CAT losses compared to YTD 2023.

Casualty

$8.0

(1.2)

The increase in losses incurred was driven by the 5.8% increase in net premiums earned.

The improvement in loss ratio was driven by lower prior year adverse loss development, which contributed 4.3 percentage points. This was primarily driven from significant adverse loss development in our legacy Motor class in 2023, whereas we had favorable loss development for this class in 2024.

Other

$22.0

12.5

The increase in losses incurred was driven by the 26.0% increase in net premiums earned, coupled with higher CAT losses.

The current year CAT losses contributed 14.5 percentage points to the total loss ratio, which was driven by the Baltimore bridge collapse and satellite failures. The change in business mix also contributed to the increase in loss ratio. This was partially offset by 6.4 percentage points from prior year favorable loss development, primarily in our Mortgage and Marine and Energy classes of business.

Acquisition Costs, Net

For Q2 2024 and YTD 2024, our total acquisition costs increased by 31.8% to $50.5 million, and by 15.4% to $92.1 million, respectively, compared to the same periods in 2023, mainly due to growth in net premiums earned and higher commissions, predominantly in our Casualty and Other lines of business. The acquisition cost ratios by line of business were as follows:

Return to table of contents


	Three months ended June 30						Six months ended June 30
	2024		2023		Increase / (decrease) in acquisition cost ratio points		2024		2023		Increase / (decrease) in acquisition cost ratio points
Property	10.7	%	19.1	%	(8.4)	%	15.8	%	19.1	%	(3.3)	%
Casualty	36.9		30.5		6.4		32.0		30.5		1.5
Other	31.0		25.1		5.9		28.3		28.1		0.2
Total	31.9	%	27.4	%	4.5	%	28.8	%	28.2	%	0.6	%

The following provides further details on the change in Q2 2024 vs. Q2 2023.


Change in Acquisition Cost Ratios
Three months ended June 30, 2024
	Increase / (decrease) in acquisition cost ratio points	Explanation
Property	(8.4)	The decrease was driven by the change in business mix as a result of not renewing a U.S. homeowner’s program that had a higher acquisition cost ratio compared to the increase in net premiums earned from CAT retro quota share treaties at lower acquisition costs.
Casualty	6.4	The increase was driven primarily due to higher than previously estimated acquisition costs for certain 2023 and 2024 FAL business within our Multi-line class. This was partially offset by a change in business mix, particularly with growth in net premiums earned from General Liability and Motor Liability classes of business at lower acquisition costs.
Other	5.9	The increase was driven primarily by the prior year favorable loss reserve releases during the quarter for certain mortgage programs within our Financial class, which resulted in higher performance-based commission costs. There was no comparable favorable loss reserves release for this business in Q2 2023, which would have triggered additional commission costs.

The following provides further details on the change in YTD 2024 vs. YTD 2023.


Change in Acquisition Cost Ratios
Six months ended June 30, 2024
	Increase / (decrease) in acquisition cost ratio points	Explanation
Property	(3.3)	Same trends as noted for Q2 2024.
Casualty	1.5	Same trends as noted for Q2 2024.
Other	0.2	Same trends as noted for Q2 2024. However, this was offset partially by the change in business mix as a result of the growth in our Marine and Energy class at lower acquisition costs.

Return to table of contents

Ratio Analysis

The following table provides our underwriting ratios by line of business for the respective periods:


	Three months ended June 30								Three months ended June 30
	2024								2023
	Property		Casualty		Other		Total		Property		Casualty		Other		Total

Loss ratio	116.8	%	68.0	%	41.2	%	64.4	%	103.1	%	60.9	%	51.6	%	64.7	%
Acquisition cost ratio	10.7		36.9		31.0		31.9		19.1		30.5		25.1		27.4
Composite ratio	127.5	%	104.9	%	72.2	%	96.3	%	122.2	%	91.4	%	76.7	%	92.1	%
Underwriting expense ratio							3.5								4.1
Combined ratio							99.8	%							96.2	%

Our combined ratio increased by 3.6 percentage points for the current quarter compared to Q2 2023 predominantly due to higher acquisition cost ratio; partially offset by a decrease in loss ratio and underwriting expense ratio. The underwriting expense ratio improved as a result of higher volume of net premium earned to cover underwriting expenses and, to a lesser extent, a net gain from deposit-accounted contracts as a result of a favorable commutation during the quarter.


	Six months ended June 30								Six months ended June 30
	2024								2023
	Property		Casualty		Other		Total		Property		Casualty		Other		Total

Loss ratio	79.9	%	65.6	%	61.1	%	66.1	%	98.6	%	66.8	%	48.6	%	66.3	%
Acquisition cost ratio	15.8	%	32.0	%	28.3	%	28.8	%	19.1	%	30.5	%	28.1	%	28.2	%
Composite ratio	95.7	%	97.6	%	89.4	%	94.9	%	117.7	%	97.3	%	76.7	%	94.5	%
Underwriting expense ratio							4.0	%							3.5	%
Combined ratio							98.9	%							98.0	%

Our combined ratio increased by 0.9 percentage points for YTD 2024 compared to same period in 2023 predominantly due to higher acquisition cost ratio and underwriting expense ratio (see G&A Expenses below for further details); partially offset by a decrease in loss ratio.

General and Administrative (“G&A”) Expenses

The breakdown of our G&A expenses between underwriting and corporate functions was as follows:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Underwriting expenses	$	5,811	$	5,468	$	12,150	$	9,407
Corporate expenses	4,706		4,557		9,081		10,554
General and administrative expenses	$	10,517	$	10,025	$	21,231	$	19,961

G&A increased by 4.9% for Q2 2024, compared to Q2 2023. The increase was driven by:

•Underwriting expenses: Increased by $0.3 million or 6.3%, predominantly due to an increase in headcount to drive business growth, coupled with an increase in professional fees and outsourced services relating to underwriting activities. Further, Q2 2023 included a bad debt charge of $0.6 million, with no similar charge during Q2 2024.

•Corporate expenses: No significant change for the quarter.

Return to table of contents

G&A increased by 6.4% for YTD 2024, compared to same period in 2023. The increase was driven by:

•Underwriting expenses: Increased by $2.7 million or 29.2%, predominantly due to an increase in headcount to drive business growth, coupled with an increase in professional fees and outsourced services relating to underwriting activities. As a result, this contributed to the net increase in underwriting expense ratio in the YTD 2024 compared to the same period in 2023.

•Corporate expenses: Decreased by $1.5 million or 14.0%, driven mainly by non-recurring severance costs included in YTD 2023 and lower outside legal costs following the hiring of our new General Counsel in April 2023.

Total Investment Income

A summary of our total investment income is as follows:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Interest and dividend income, net of withholding taxes and other expenses	8,135		8,863		$	16,691	$	17,491
Net realized and unrealized gains on other investments (see Note 4)	89		506		(324)		256
Net investment-related income	$	8,224	$	9,369	$	16,367	$	17,747
Share of Solasglas' net income (see Note 3)	4,330		32,782		22,578		29,644
Total investment income	$	12,554	$	42,151	$	38,945	$	47,391

Net investment-related income

Our net investment-related income decreased by 8.2% compared to Q2 2023, and by 4.6% compared to YTD 2023, mainly driven by the decrease in interest income earned from restricted cash and cash equivalents as a result of decreases in the outstanding collateral balance during both periods.

Share of Solasglas’ net income

For Q2 2024 and YTD 2024, Solasglas reported a gain of 1.2% and 6.4%, respectively, compared to a gain of 10.9% and 9.7% for Q2 2023 and YTD 2023, respectively. The following table provides a breakdown of the gross and net investment return for Solasglas.


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Long portfolio gains (losses)	(1.0)	%	18.0	%	3.4	%	27.3	%
Short portfolio gains (losses)	1.6		(5.5)		1.7		(14.8)
Macro gains (losses)	0.9		0.3		2.9		(0.1)
Other income and expenses 1	(0.2)		(0.8)		(0.9)		(1.6)
Gross investment return	1.3	%	12.0	%	7.1	%	10.8	%
Net investment return 1	1.2	%	10.9	%	6.4	%	9.7	%

1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 3.

For Q2 2024, the significant contributors to Solasglas’ investment return were long positions in Solvay (Belgium: SOLB), HP (HPQ), and Kyndryl Holdings (KD). The largest detractors were long positions in Brighthouse Financial (BHF), Green Brick Partners (GRBK), and a single-name short position.

For YTD 2024, the significant contributors to Solasglas’ investment return were long positions in GRBK, gold, and Tenet Healthcare (THC). The largest detractors were a long position in BHF and two single-name short positions.

Return to table of contents

Each month, we post on our website (www.greenlightre.com) the returns from our investment in Solasglas.

Financial Condition

Investments

The following table provides a breakdown of our total investments:


	June 30				December 31
	2024				2023
Investment in related party investment fund (Solasglas)	$	351,468	82.8	%	$	258,890	78.0	%
Other investments:
Private investments and unlisted equities	71,866		16.9		71,157		21.4
Debt and convertible debt securities	1,293		0.3		2,136		0.6

Total other investments	$	73,159	17.2	%	$	73,293	22.0	%

Total investments	$	424,627	100.0	%	$	332,183	100.0	%

At June 30, 2024, our total investments increased by $92.4 million, or 27.8%, to $424.6 million from December 31, 2023. The increase was primarily driven by $70.0 million of additional contributions into Solasglas, coupled with the net investment return for Q2 2024. The contributions were funded partially from cash flow from operations and partially from the release of restricted cash.

Investments in Solasglas

DME Advisors reports the composition of Solasglas’ portfolio on a delta-adjusted basis, which it believes is the appropriate manner to assess the exposure and profile of investments and reflects how it manages the portfolio. An option’s delta is the option price’s sensitivity to the underlying stock (or commodity) price. The delta-adjusted basis is the number of shares or contracts underlying the option multiplied by the delta and the underlying stock (or commodity) price.

The following table represents the composition of Solasglas’ investments:


	June 30				December 31
	2024				2023
	Long %		Short %		Long %		Short %
Equities and related derivatives	79.4	%	38.2	%	90.2	%	53.8	%
Private and unlisted equity securities	2.0		—		2.0		—
Debt instruments	0.3		—		0.3		—
Total	81.7	%	38.2	%	92.5	%	53.8	%

The above exposure analysis does not include cash (U.S. dollar and foreign currencies), gold and other commodities, credit default swaps, sovereign debt, foreign currency derivatives, interest rate derivatives, inflation swaps and other macro positions. Under this methodology, a total return swap’s exposure is reported at its full notional amount and options are reported at their delta-adjusted basis. At June 30, 2024, Solasglas’ exposure to gold on a delta-adjusted basis was 7.5% (2023: 11.2%).

At June 30, 2024, 94.3% of Solasglas’ portfolio was valued based on quoted prices in actively traded markets (Level 1), 4.1% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and a nominal amount was composed of instruments valued based on non-observable inputs (Level 3). At June 30, 2024, 1.6% of Solasglas’ portfolio consisted of private equity funds valued using the funds’ net asset values as a practical expedient.

Return to table of contents

Other Investments

The other investment holdings relate to private investments made by Innovations. During Q2 2024, we made two modest private equity investments. During the YTD 2024, we impaired certain debt securities (see Note 4), resulting in a decrease in the carrying value of these securities.

Restricted cash and cash equivalents

We use our restricted cash and cash equivalents primarily for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash decreased by $42.7 million, or 7.1%, from $604.6 million at December 31, 2023, to $561.9 million at June 30, 2024, primarily due to release of collateral from our ceding insurers relating to legacy contracts in run-off.

Reinsurance balances receivable

Our reinsurance balances receivable increased by $67.3 million, or 10.9%, to $686.7 million from $619.4 million at December 31, 2023. This increase was driven primarily by the renewal of reinsurance treaties, in addition to new business bound during 2024.

Loss and LAE Reserves; Loss and LAE Recoverable

Our reserves for loss and LAE by lines of business were as follows:


	June 30, 2024						December 31, 2023
	Case Reserves		IBNR		Total		Case Reserves		IBNR		Total

Property	$	33,531	$	49,708	$	83,239	$	24,181	$	41,056	$	65,237
Casualty	139,286		317,563		456,849		136,713		299,933		436,646
Other	37,985		174,684		212,669		28,156		131,515		159,671
Total	$	210,802	$	541,955	$	752,757	$	189,050	$	472,504	$	661,554

Our total gross loss and LAE reserves increased by $91.2 million, or 13.8%, to $752.8 million from $661.6 million at December 31, 2023. This increase is primarily driven by the increase in earned premium from the renewal of reinsurance treaties and new business, offset partially by paid losses during Q2 2024. See Note 7 “Loss and Loss Adjustment Expense Reserves” of the financial statements for a summary of changes in outstanding loss and LAE reserves and a description of prior period loss developments.

Our total loss and LAE recoverable increased by $33.0 million, or 128.3%, to $58.6 million from $25.7 million at December 31, 2023. This increase was driven mainly by the loss recoveries on the Baltimore bridge loss event, the Taiwan earthquake (gross losses were mostly retroceded), and the increase in quota share retrocessions for Other Specialty business due to growth from inward premiums. See Note 8 “Retrocessio n” of the financial statements for a description of the credit risk associated with our retrocessionaires.

Probable Maximum Loss (“PML”)

At July 1, 2024, our estimated largest PML at a 1-in-250-year return period for a single event, and in aggregate, was $99.9 million and $109.2 million, respectively, both relating to the peril of North Atlantic Hurricane, compared to $103.3 million and $111.5 million, respectively, at April 1, 2024.

Return to table of contents

The below table contains the expected modeled loss for each of our peak peril regions and sub-regions for both a single event loss and aggregate loss measures at the 1-in-250-year return period.


	July 1, 2024
	Net 1-in-250 Year Return Period
Peril	Single Event Loss		Aggregate Loss

North Atlantic Hurricane	$	99,856	$	109,207
Southeast Hurricane	94,455		94,455
Gulf of Mexico Hurricane	52,552		52,715
Northeast Hurricane	54,688		55,167
North America Earthquake	95,487		96,748
California Earthquake	83,828		86,690
Pacific Northwest Earthquake	49,540		49,540
Other N.A. Earthquake	48,328		48,391
Japan Earthquake	37,941		38,491
Japan Windstorm	22,120		23,419
Europe Windstorm	60,870		64,018

Debt

Our total debt decreased by $11.7 million, or 15.9%, to $61.6 million from $73.3 million at December 31, 2023 due to partial repayment. Refer to Note 9 “Debt and Credit Facil ities” of the financial statements for further information.

Total shareholders’ equity

Total shareholders’ equity increased by $37.9 million to $634.0 million, compared to $596.1 million at December 31, 2023. The increase was primarily due to the net income of $35.0 million reported for the period. For details of other movements in shareholders’ equity, see the condensed consolidated statements of shareholders’ equity.

Return to table of contents

Liquidity and Capital Resources

Refer to the “Liquidity and Capital Resources” section included in Item 7 of our 2023 Form 10-K for a general discussion of our liquidity and capital resources.

Liquidity

The following table summarizes our sources and uses of funds:


	Six months ended June 30
	2024		2023
Total cash provided by (used in):
Operating activities	$	40,669	$	566
Investing activities	(70,246)		(7,049)
Financing activities	(11,876)		(17,085)
Effect of currency exchange on cash(1)	(107)		351
Net cash inflows (outflows)	(41,560)		(23,217)
Cash, beginning of period	655,730		706,548
Cash, end of period	$	614,170	$	683,331

(1) Cash includes unrestricted and restricted cash and cash equivalents - see Note 5 of the financial statements.

Cash provided by operating activities

The increase in cash provided by operating activities was driven mainly by the ebb and flow from our underwriting activities, which may vary significantly from period to period depending on the mix of business, the nature of underwriting opportunities available and volume of claims submitted to us by our cedents.

Cash used in investing activities

The increase in cash used for investing activities was driven mainly by the net change in our investment in Solasglas where we made a net contribution of $70.0 million for YTD 2024 compared to a net contribution of $9.0 million during the same period in 2023.

Cash used in financing activities

The decrease in cash used in our financing activities was driven mainly by the repurchase of a portion of the outstanding Convertible Notes in the first half of 2023. In Q2 2024, we partially repaid $11.7 million of the Term loans.

Capital Resources

The following table summarizes our debt and capital structure:


	June 30, 2024			December 31, 2023
Debt	$	62,188		$	74,062
Shareholders’ equity	$	634,020		$	596,095


Ratio of debt to shareholders’ equity	9.7		%	12.4		%

The debt to shareholders’ equity provides an indication of our leverage and capital structure, along with some insights into our financial strength. In addition to the above capital, we also have LOC facilities to support our reinsurance business operations where we are not licensed or admitted as a reinsurer.

Our shareholders’ equity increased in YTD 2024 primarily due to net income for the period.

Return to table of contents

Ordinary Shares

At June 30, 2024, there were 35,321,144 outstanding ordinary shares, a decrease of 15,588 since December 31, 2023, due to forfeited performance restricted shares net of issuance of ordinary shares for vested RSUs.

We did not repurchase any ordinary shares for the six months ended June 30, 2024.

We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have renewed our $200.0 million shelf registration by filing the Form S-3 registration statement with the SEC, which became effective on July 5, 2024, and will expire on July 1, 2027.

Secured LOC Facilities

As disclosed in Note 9 “Debt and Credit Facilities” of Q2 2024 Financials, the $275 million committed capacity under the Citi LOC agreement will terminate on August 20, 2024. However, Citi informed the Company that it intends to continue providing the Citi LOC on an uncommitted basis for the foreseeable future following the termination date.

Contractual Obligations and Commitments

At June 30, 2024, our contractual obligations and commitments by period due were as follows:


	Less than 1 year		1-3 years		3-5 years		More than 5 years		Total
Operating activities
Loss and loss adjustment expense reserves (1)	$	357,560	$	238,624	$	88,825	$	67,748	$	752,757
Operating lease obligations	686		726		—		—		1,412
Financing activities
Debt (2)	2,813		59,375		—		—		62,188
Total	$	361,059	$	298,725	$	88,825	$	67,748	$	816,357

(1) Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.

(2) See Note 9 “Debt and Credit Facilities” of the financial statements.

Critical Accounting Estimates

Our financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part II. Item 1A. Risk Factors” included in our 2023 Form 10-K, cause actual events or results to differ materially from our underlying assumptions or estimates. In that case, there could be a material adverse effect on our results of operations, financial condition, or liquidity. The most significant estimates relate to: premium revenues and risk transfer, loss and loss adjustment expense reserves, investment impairments, allowances for credit losses, and share-based compensation.

We believe that the critical accounting estimates discussion in “Part II. Item 7. — Management’s Discussion and Analysis of Financial Condition and Results on Operations” of our 2023 Form 10-K continues to describe the significant estimates and judgments included in the preparation of these financial statements.

Recent Accounting Pronouncements

At June 30, 2024, there were no recently issued accounting pronouncements that we have not yet adopted that we expect could have a material impact on our results of operations, financial condition, or liquidity. See Note 2 “Significant Accounting Policies” of the Q2 2024 Financials.

Return to table of contents

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to Item 7A included in our 2023 Form 10-K. There have been no material changes to this item since December 31, 2023.

Item 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.

Return to table of contents

PART II — OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results.

Item 1A. RISK FACTORS

Factors that could cause our actual results to differ materially from those in this report are any of the risks described in “Part I. Item 1A. Risk Factors” included in our 2023 Form 10-K, as filed with the SEC on March 5, 2024. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of June 30, 2024, there have been no other material changes to the risk factors disclosed in “Part I. Item 1A. Risk Factors” included in our 2023 Form 10-K. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Our Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. On May 3, 2024, our Board of Directors re-approved the share repurchase plan until June 30, 2025, authorizing us to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. Any shares repurchased are canceled immediately upon repurchase. We are not required to repurchase any of the ordinary shares. The repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

There were no share repurchases made under the plan during the three months ended June 30, 2024.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

Our directors and executive officers may purchase or sell shares of our ordinary shares in the market from time to time, including pursuant to equity trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”) and in compliance with guidelines specified by the Company. In accordance with Rule 10b5-1 and our insider trading policy, directors, officers, and certain employees who, at such time, are not in possession of material non-public information about the Company are permitted to enter into written plans that pre-establish amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s equity plans (“Rule 10b5-1 Trading Plans”). Under Rule 10b5-1 Trading Plan, a broker executes trades pursuant to parameters established by the director or executive officer when entering into the plan, without further direction from them.

Return to table of contents

During the three months ended June 30, 2024, we did not have any Rule 10b5-1 trading arrangements or any “non-Rule 10b5-1 arrangements” (as defined in Item 408(a) of Regulation S-K) in place for our directors and officers.

Item 6. EXHIBITS


10.1			Amendment No. 3 to Shareholders A g re ement dated and effective as of May 30, 2024.
31.1			Certification of the Chief Executive Officer filed hereunder pursuant to Section 302 of the Sarbanes Oxley Act of 2002
31.2			Certification of the Chief Financial Officer filed hereunder pursuant to Section 302 of the Sarbanes Oxley Act of 2002
32.1			Certification of the Chief Executive Officer filed hereunder pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (*)
32.2			Certification of the Chief Financial Officer filed hereunder pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (*)
101			The following materials from the Company’s Quarterly Report on Form 10-Q for the three and six months ended June 30, 2024 formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


			* Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


			GREENLIGHT CAPITAL RE, LTD.
			(Registrant)
			By:			/s/ GREGORY RICHARDSON
						Gregory Richardson Director and Chief Executive Officer (principal executive officer)
						August 6, 2024

			By:			/s/ FARAMARZ ROMER
						Faramarz Romer Chief Financial Officer (principal financial and accounting officer)
						August 6, 2024

EXHIBIT 31.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

I, Gregory Richardson, certify that:


1.			I have reviewed this quarterly report report on Form 10-Q of Greenlight Capital Re, Ltd.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.			The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Dated:	August 6, 2024	/s/ GREGORY RICHARDSON
		Gregory Richardson Chief Executive Officer (principal executive officer)

EXHIBIT 31.2

CERTIFICATION OF

CHIEF FINANCIAL OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

I, Faramarz Romer, certify that:


1.			I have reviewed this quarterly report report on Form 10-Q of Greenlight Capital Re, Ltd.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


5.			The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Dated:	August 6, 2024	/s/ FARAMARZ ROMER
		Faramarz Romer
		Chief Financial Officer
		(principal financial officer)

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the "Form 10-Q") for the period ended June 30, 2024 of Greenlight Capital Re, Ltd. (the "Issuer").

I, Gregory Richardson, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge:

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.


Dated:	August 6, 2024	/s/ GREGORY RICHARDSON
		Gregory Richardson Chief Executive Officer (principal executive officer)

EXHIBIT 32.2

CERTIFICATION OF

CHIEF FINANCIAL OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the period ended June 30, 2024 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’).

I, Faramarz Romer, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge:

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.


Dated:	August 6, 2024	/s/ FARAMARZ ROMER
		Faramarz Romer
		Chief Financial Officer
		(principal financial officer)

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2024	Aug. 02, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-33493
Entity Registrant Name	GREENLIGHT CAPITAL RE, LTD.
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	65 Market Street
Entity Address, Address Line Two	Suite 1207, Jasmine Court
Entity Address, Address Line Three	P.O. Box 31110
Entity Address, City or Town	Camana Bay
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-1205
City Area Code	205
Local Phone Number	291-3440
Title of 12(b) Security	Ordinary Shares
Trading Symbol	GLRE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		35,321,144
Entity Central Index Key	0001385613
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments
Investment in related party investment fund, at fair value	$ 351,468	$ 258,890
Other investments	73,159	73,293
Total investments	424,627	332,183
Cash and cash equivalents	52,240	51,082
Restricted cash and cash equivalents	561,930	604,648
Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854)	686,743	619,401
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $701 and 2023: $487)	58,647	25,687
Deferred acquisition costs	83,305	79,956
Unearned premiums ceded	28,184	17,261
Other assets	4,272	5,089
Total assets	1,899,948	1,735,307
Liabilities
Loss and loss adjustment expense reserves	752,757	661,554
Unearned premium reserves	349,015	306,310
Reinsurance balances payable	76,253	68,983
Funds withheld	18,266	17,289
Other liabilities	8,042	11,795
Debt	61,595	73,281
Total liabilities	1,265,928	1,139,212
Commitments and Contingencies (Note 15)
Shareholders' equity
Preferred share capital (par value $0.10; none issued)	0	0
Ordinary share capital (par value $0.10; issued and outstanding, 35,321,144) (2023: par value $0.10; issued and outstanding, 35,336,732)	3,532	3,534
Additional paid-in capital	487,462	484,532
Retained earnings	143,026	108,029
Total shareholders' equity	634,020	596,095
Total liabilities and equity	$ 1,899,948	$ 1,735,307

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for expected credit losses	$ 865	$ 854
Loss and loss adjustment expenses recoverable, allowance	$ 701	$ 487
Preferred share capital, par value (in dollars per share)	$ 0.10	$ 0.10
Preferred share capital, issued (in shares)	0	0
Ordinary share capital, par value (in dollars per share)	$ 0.10	$ 0.10
Ordinary share capital, issued (in shares)	35,321,144	35,336,732
Ordinary share capital, outstanding (in shares)	35,321,144	35,336,732

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Gross premiums written	$ 168,975	$ 154,943	$ 386,233	$ 341,398
Gross premiums ceded	(14,832)	(9,739)	(38,013)	(20,951)
Net premiums written	154,143	145,204	348,220	320,447
Change in net unearned premium reserves	4,255	(5,261)	(28,286)	(37,855)
Net premiums earned	158,398	139,943	319,934	282,592
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3)	4,330	32,782	22,578	29,644
Net investment income	8,224	9,369	16,367	17,747
Foreign exchange gains (losses)	(932)	4,729	(2,581)	9,660
Other income, net	4,843	2,866	9,878	5,032
Total revenues	174,863	189,689	366,176	344,675
Expenses
Net loss and loss adjustment expenses incurred	102,033	90,504	211,359	187,229
Acquisition costs	50,454	38,293	92,064	79,769
General and administrative expenses	10,517	10,025	21,231	19,961
Deposit interest expense	1,886	235	2,762	367
Interest expense	1,560	744	2,809	1,520
Total expenses	166,450	139,801	330,225	288,846
Income before income tax	8,413	49,888	35,951	55,829
Income tax expense	(435)	(28)	(954)	(82)
Net income	$ 7,978	$ 49,860	$ 34,997	$ 55,747
Earnings (loss) per share ("EPS"):
Basic (in dollars per share)	$ 0.23	$ 1.46	$ 1.02	$ 1.64
Diluted (in dollars per share)	$ 0.23	$ 1.32	$ 1.01	$ 1.49
Weighted average number of ordinary shares used in the determination of EPS:
Basic (in shares)	34,238,863	34,070,818	34,255,454	34,065,066
Diluted (in shares)	34,699,182	38,267,137	34,679,325	38,322,921

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Ordinary share capital	Additional paid-in capital	Retained earnings
Beginning balance at Dec. 31, 2022		$ 3,482	$ 478,439	$ 21,199
Increase (Decrease) in Stockholders' Equity
Issue of ordinary shares, net of forfeitures		45
Share-based compensation expense			2,209
Net income	$ 55,747			55,747
Ending balance at Jun. 30, 2023	561,121	3,527	480,648	76,946
Beginning balance at Mar. 31, 2023		3,526	479,429	27,086
Increase (Decrease) in Stockholders' Equity
Issue of ordinary shares, net of forfeitures		1
Share-based compensation expense			1,219
Net income	49,860			49,860
Ending balance at Jun. 30, 2023	561,121	3,527	480,648	76,946
Beginning balance at Dec. 31, 2023		3,534	484,532	108,029
Increase (Decrease) in Stockholders' Equity
Issue of ordinary shares, net of forfeitures		(2)
Share-based compensation expense			2,930
Net income	34,997			34,997
Ending balance at Jun. 30, 2024	634,020	3,532	487,462	143,026
Beginning balance at Mar. 31, 2024		3,532	485,878	135,048
Increase (Decrease) in Stockholders' Equity
Share-based compensation expense			1,584
Net income	7,978			7,978
Ending balance at Jun. 30, 2024	$ 634,020	$ 3,532	$ 487,462	$ 143,026

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities
Net income	$ 34,997	$ 55,747
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities:
Income from investments in related party investment fund	(22,578)	(29,644)
Net realized gain on repurchases of convertible senior notes payable	0	(265)
Net realized and unrealized losses (gains) on other investments	324	(256)
Net realized and unrealized losses (gains) on derivatives	(565)	0
Current expected credit losses (gains) recognized on reinsurance assets	225	500
Share-based compensation expense	2,928	2,254
Accretion of debt offering costs and change in interest accruals	190	(59)
Net change in:
Reinsurance balances receivable	(67,353)	(111,672)
Loss and loss adjustment expenses recoverable	(33,174)	(8,316)
Deferred acquisition costs	(3,349)	(626)
Unearned premiums ceded	(10,923)	(1,074)
Loss and loss adjustment expense reserves	91,203	65,633
Unearned premium reserves	42,705	30,234
Reinsurance balances payable	7,270	4,399
Funds withheld	977	(6,302)
Other items, net	(2,208)	13
Net cash provided by (used in) operating activities	40,669	566
Cash flows from investing activities
Proceeds from redemptions of investment in Solasglas	0	37,997
Contributions to investment in Solasglas	(70,000)	(47,001)
Purchases of other investments	(414)	(4,045)
Proceeds on disposal of other investments	168	6,000
Net cash provided by (used in) investing activities	(70,246)	(7,049)
Cash flows from financing activities
Repayment of term loans	(11,876)	0
Repurchases of convertible senior notes payable	0	(17,085)
Net cash used in financing activities	(11,876)	(17,085)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(107)	351
Decrease in cash, cash equivalents and restricted cash	(41,560)	(23,217)
Cash, cash equivalents and restricted cash at beginning of the period	655,730	706,548
Cash, cash equivalents and restricted cash at end of the period	614,170	683,331
Supplementary information
Interest paid in cash	3,315	1,578
Income tax paid (refund received) in cash	$ 153	$ 21

ORGANIZATION AND BASIS OF PRESENTATION	6 Months Ended
ORGANIZATION AND BASIS OF PRESENTATION	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	ORGANIZATION AND BASIS OF PRESENTATION Organization Greenlight Capital Re, Ltd. (“GLRE” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.” Basis of Presentation These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2023 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation. In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year. Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars. Reclassifications Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2024
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES There were no material changes to the Company’s significant accounting policies subsequent to its 2023 Form 10-K. Recently Issued Accounting Standards Not Yet Adopted On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted. On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements. As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.

INVESTMENT IN RELATED PARTY INVESTMENT FUND

6 Months Ended

Jun. 30, 2024

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENT IN RELATED PARTY INVESTMENT FUND

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP


	June 30, 2024		December 31, 2023
Assets
Investments, at fair value	$	401,510	$	453,358
Derivative contracts, at fair value	11,244		11,167
Due from brokers	169,898		121,754
Cash and cash equivalents	53,460		—
Interest and dividends receivable	195		1,143
Total assets	636,307		587,422

Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value	(162,984)		(197,571)
Derivative contracts, at fair value	(11,147)		(12,917)
Capital withdrawals payable	—		(1,000)
Due to brokers	—		(17,398)
Interest and dividends payable	(1,404)		(2,315)
Accrued expenses and other liabilities	(164)		(247)
Total liabilities	(175,699)		(231,448)

Partners' capital	$	460,608	$	355,974

GLRE’s share of Partners' capital	$	351,468	$	258,890

Summarized Statements of Operations of Solasglas Investments, LP


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Investment income
Dividend income (net of withholding taxes)	$	941	$	724	$	1,772	$	1,351
Interest income	2,148		2,076		6,500		3,892
Total Investment income	3,089		2,800		8,272		5,243

Expenses
Management fee	(1,408)		(1,163)		(2,731)		(2,231)
Interest	(736)		(1,579)		(2,070)		(3,007)
Dividends	(731)		(793)		(1,435)		(1,212)
Professional fees and other	(335)		(607)		(659)		(889)
Total expenses	(3,210)		(4,142)		(6,895)		(7,339)

Net investment income (loss)	(121)		(1,342)		1,377		(2,096)

Realized and change in unrealized gains (losses)
Net realized gain (loss)	20,085		(845)		63,030		(2,605)
Net change in unrealized appreciation (depreciation)	(13,138)		54,825		(29,383)		53,792
Net gain (loss) on investment transactions	6,947		53,980		33,647		51,187

Net increase (decrease) in Partners' capital (1)	$	6,826	$	52,638	$	35,024	$	49,091

GLRE’s share of the increase (decrease) in Partners' capital	$	4,330	$	32,782	$	22,578	$	29,644

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Management fees	$	1,408	$	1,163	$	2,731	$	2,231
Performance allocation	481		$	3,294	2,509		3,294
Total	$	1,889	$	4,457	$	5,240	$	5,525

OTHER INVESTMENTS

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

OTHER INVESTMENTS

At June 30, 2024, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	27,170	$	49,902	$	(5,206)	$	—	$	71,866
Debt and convertible debt securities	2,713		—		(1,510)		90		1,293

Total other investments	$	29,883	$	49,902	$	(6,716)	$	90	$	73,159

At December 31, 2023, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	28,470	$	49,424	$	(6,737)	$	—	$	71,157
Debt and convertible debt securities	2,499		—		(499)		136		2,136

Total other investments	$	30,969	$	49,424	$	(7,236)	$	136	$	73,293


	Six months ended June 30
	2024		2023
Carrying value (1)	$	71,866	$	65,904
Upward carrying value changes (2)	$	501	$	506
Downward carrying value changes and impairment (3)	$	(114)	$	(250)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.

(2) The cumulative upward carrying value changes from inception to June 30, 2024, totaled $50.9 million.

(3) The cumulative downward carrying value changes and impairments from inception to June 30, 2024, totaled $2.8 million.

Net investment income


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross realized gains	$	—	$	—	$	—	$	—
Gross realized losses	—		—		(1,332)		(800)
Net realized gains (losses)	$	—	$	—	$	(1,332)	$	(800)
Change in unrealized gains	89		506		1,008		1,056
Net realized and unrealized gains (losses) on other investments	$	89	$	506	$	(324)	$	256

RESTRICTED CASH AND CASH EQUIVALENTS

6 Months Ended

Jun. 30, 2024

Cash and Cash Equivalents [Abstract]

RESTRICTED CASH AND CASH EQUIVALENTS


	June 30, 2024		December 31, 2023
Restricted cash and cash equivalents:
Cash securing trust accounts	$	274,275	$	300,152
Cash securing letters of credit issued	274,048		291,456
Cash securing Loan Facility	10,000		10,000
Other	3,607		3,040
Total restricted cash and cash equivalents	561,930		604,648
Cash and cash equivalents	52,240		51,082
Total cash, cash equivalents, and restricted cash	$	614,170	$	655,730

FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Assets measured at fair value on a nonrecurring basis


	Less than 6 months		6 to 12 months		Over 1 year		Total
Fair values measured on a nonrecurring basis	$	1,423	$	26,338	$	34,086	$	61,847

Assets measured at fair value on a recurring basis

Derivative financial instruments

Financial Instruments Disclosed, But Not Carried, at Fair Value

LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

6 Months Ended

Jun. 30, 2024

Insurance Loss Reserves [Abstract]

LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:


	June 30, 2024		December 31, 2023
Case reserves	$	210,802	$	189,050
IBNR	541,955		472,504
Total	$	752,757	$	661,554

Reserve Roll-forward

The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:


Consolidated	Six months ended June 30
	2024		2023
Gross balance at January 1	$	661,554	$	555,468
Less: Losses recoverable	(25,687)		(13,239)
Net balance at January 1	635,867		542,229
Incurred losses related to:
Current year	206,647		173,428
Prior years	4,712		13,801
Total incurred	211,359		187,229
Paid losses related to:
Current year	(20,677)		(22,428)
Prior years	(129,716)		(114,056)
Total paid	(150,393)		(136,484)
Foreign currency revaluation	(2,723)		6,572
Net balance at June 30	694,110		599,546
Add: Losses recoverable (see Note 8)	58,647		21,555
Gross balance at June 30	$	752,757	$	621,101

Estimates for Significant Catastrophe Events

Gabrielle and the U.S. tornados, coupled with $3.2 million net adverse prior year CAT loss development mainly relating to the 2022 Winter Storm Elliott.

Prior Year Reserve Development

RETROCESSION

6 Months Ended

Jun. 30, 2024

Reinsurance Disclosures [Abstract]

RETROCESSION

The following table provides a breakdown of ceded reinsurance:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross ceded premiums	$	14,832	$	9,739	$	38,013	$	20,951
Earned ceded premiums	$	11,849	$	11,296	$	27,091	$	19,877
Loss and loss adjustment expenses ceded	$	14,773	$	9,537	$	37,849	$	15,708


	June 30, 2024				December 31, 2023
	Gross		Net of Collateral(1)		Gross		Net of Collateral(1)
A- or better by A.M. Best	$	33,288	$	33,288	$	8,767	$	8,767
Not rated	26,059		8,816		17,407		2,432
Total before provision	59,347		$	42,104	$	26,174	$	11,199
Provision for credit losses	(700)				(487)
Total loss and loss adjustment expenses recoverable, net	$	58,647			$	25,687

DEBT AND CREDIT FACILITIES

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

DEBT AND CREDIT FACILITIES

Debt Obligations

The following table summarizes the Company’s outstanding debt obligations.


	June 30, 2024		December 31, 2023
Term loans	$	62,188	$	74,062
Accrued interest payable	38		—
Less: deferred financing costs	(631)		(781)
Total debt	$	61,595	$	73,281

During the six months ended June 30, 2024, the Company partially repaid $11.9 million of the outstanding Term loans.

Credit Facilities

At June 30, 2024, the Company had the following letter of credit (“LOC”) facilities:


	Capacity		LOCs issued		Termination Date
Citibank Europe plc ("Citi LOC")1	$	289,000	$	231,665	August 20, 2024
CIBC Bank USA ("CIBC LOC")	200,000		42,338		December 21, 2024
	$	489,000	$	274,003

1) Includes $14 million of uncommitted capacity.

SHARE CAPITAL

6 Months Ended

Jun. 30, 2024

Equity [Abstract]

SHARE CAPITAL

Ordinary Shares

The following table is a summary of changes in ordinary shares issued and outstanding for the six months ended June 30:


	2024	2023
	Ordinary	Class A	Class B
Balance – beginning of period	35,336,732	28,569,346	6,254,715
Issue of shares, net of forfeitures	(15,588)	447,952	—



Balance – end of period	35,321,144	29,017,298	6,254,715

The Company’s authorized share capital is 125,000,000 ordinary shares, par value of $0.10 per share.

At June 30, 2024, the Company has an effective Form S-3 registration statement on file with the SEC for an aggregate principal amount of $200.0 million in securities.

Share Repurchase Plan

Preferred Shares

The Company’s authorized share capital also consists of 50,000,000 preference shares with a par value of $0.10 each. At June 30, 2024, the Company has no issued and outstanding preferred shares.

SHARE-BASED COMPENSATION

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

SHARE-BASED COMPENSATION

Employee and Director Restricted Shares

The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the six months ended June 30, 2024 and 2023:


	Performance Restricted Shares			Service Restricted Shares
	Number of non-vested restricted shares	Weighted average grant date fair value		Number of non-vested restricted shares	Weighted average grant date fair value
Balance at December 31, 2022	794,362	$	7.62	832,896	$	7.76
Granted	357,766	9.85		177,563	9.84
Vested	—	—		(256,243)	6.75
Forfeited	(109,105)	9.37		(55,967)	8.43
Balance at June 30, 2023	1,043,023	$	8.20	698,249	$	8.60

Balance at December 31, 2023	1,042,688	$	9.94	419,604	$	9.18
Granted	—	—		—	—
Vested	—	—		(217,522)	8.78
Forfeited	(89,945)	10.84		—	—
Balance at June 30, 2024	952,743	$	9.86	202,082	$	9.61

At June 30, 2024, 2,914,198 (December 31, 2023: 3,296,771) ordinary shares remained available for future issuance under the Company’s 2023 Incentive Plan.

Employee Restricted Stock Units

The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the six months ended June 30, 2024 and 2023:


	Performance RSUs			Service RSUs
	Number of non-vested RSUs	Weighted average grant date fair value		Number of non-vested RSUs	Weighted average grant date fair value
Balance at December 31, 2022	105,008	$	6.82	172,952	$	7.58
Granted	71,121	9.85		42,811	9.85
Vested	—	—		(77,695)	6.74
Forfeited	—	—		(1,788)	7.82
Balance at June 30, 2023	176,129	$	8.04	136,280	$	8.76

Balance at December 31, 2023	154,445	$	8.03	110,425	$	8.78
Granted	258,148	11.85		124,425	11.85
Vested	—	—		(74,357)	8.84
Forfeited	—	—		—	—
Balance at June 30, 2024	412,593	$	10.42	160,493	$	11.14

For the six months ended June 30, 2024, the total fair value of Service RSUs vested was $0.7 million (2023: $0.5 million).

Employee and Director Stock Options



Expected volatility	36.4		%
Expected term (in years)	5
Expected dividend yield	—		%
Risk-free interest rate	3.9		%
Stock price at grant date	$	11.20

Stock Compensation Expense

EARNINGS PER SHARE

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

EARNINGS PER SHARE

The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and six months ended June 30, 2024 and 2023:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Numerator for EPS
Net income - basic	$	7,978	$	49,860	$	34,997	$	55,747
Add: interest on convertible notes	—		744		—		1,520
Less: gain on repurchase of convertible notes	—		—		—		(265)
Net income - diluted	$	7,978	$	50,604	$	34,997	$	57,002

Denominator for EPS
Weighted average shares outstanding - basic	34,238,863		34,070,818		34,255,454		34,065,066
Effect of dilutive employee and director share-based awards	460,319		580,494		423,871		534,958
Shares potentially issuable in connection with convertible notes	—		3,615,825		—		3,722,897
Weighted average shares outstanding - diluted	34,699,182		38,267,137		34,679,325		38,322,921
Anti-dilutive stock options outstanding	902,140		690,337		902,140		690,337


EPS:
Basic	$	0.23	$	1.46	$	1.02	$	1.64
Diluted	$	0.23	$	1.32	$	1.01	$	1.49

NET INVESTMENT INCOME

6 Months Ended

Jun. 30, 2024

Net Investment Income [Abstract]

NET INVESTMENT INCOME

The following table provides a breakdown of net investment income:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Interest and dividend income, net of withholding taxes and other expenses	$	8,135	$	8,863	$	16,691	$	17,491
Net realized and unrealized gains on other investments (see Note 4)	89		506		(324)		256
Net investment-related income	8,224		9,369		16,367		17,747
Share of Solasglas' net income (see Note 3)	4,330		32,782		22,578		29,644
Total investment income	$	12,554	$	42,151	$	38,945	$	47,391

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Investment Advisory Agreement There has been no change to the Company’s agreement with Solasglas as described in its 2023 Form 10-K. Refer to Note 3 for a breakdown of management fees and performance fees for the six months ended June 30, 2024 and 2023. Green Brick Partners, Inc. David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At June 30, 2024, Solasglas, along with certain affiliates of DME Advisors, collectively owned 25.2% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in Solasglas. At June 30, 2024, Solasglas held 1.8 million shares of GRBK. Subsequent to June 30, 2024, Solasglas reduced its exposure to GRBK and as of July 31, 2024 held 1.3 million shares of GRBK. Service Agreement The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. Collateral Assets Investment Management Agreement Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the Solasglas LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

a) Concentration of Credit Risk

Cash and cash equivalents

The Company monitors its concentration of credit risk with financial institutions and limits acceptable counterparties based on current rating, outlook and other relevant factors.

Investments

The Company’s credit risk exposure to private debt and convertible debt securities within its “Other investments” are immaterial (see Note 4).

Reinsurance balances receivable, net

The following table shows the breakdown of reinsurance balances receivable:


	June 30, 2024				December 31, 2023
	Amount		%		Amount		%
Premiums receivable	$	260,801	38.0	%	$	186,940	30.2	%

Funds withheld:
Funds held by cedants	48,790		7.1	%	50,075		8.1	%
Premiums held by Lloyds' syndicates	264,685		38.5	%	264,278		42.7	%
Funds at Lloyd’s	110,624		16.1	%	115,772		18.6	%

Profit commission receivable	2,708		0.4	%	2,302		0.4	%

Deposit assets	—		—	%	888		0.1	%
Total before provision	687,608		100.1	%	620,255		100.1	%
Provision for expected credit losses	(865)		(0.1)	%	(854)		(0.1)	%
Reinsurance balances receivable, net	$	686,743	100.0	%	$	619,401	100.0	%

The Company has posted deposits at Lloyd’s to support underwriting capacity for certain syndicates, including Syndicate 3456. Lloyd’s has a credit rating of “A” (Excellent) from A.M. Best.

Loss and loss adjustment expenses recoverable, net

b) Lease Obligations

There was no material change to the Company’s operating lease agreements subsequent to its 2023 Form 10-K.

c) Litigation

SEGMENT REPORTING

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

SEGMENT REPORTING

The Company has one operating segment: Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property
Commercial	$	12,070	7.1	%	$	14,440	9.3	%	$	30,236	7.8	%	$	29,131	8.5	%
Motor	93		0.1		352		0.2		155		—		584		0.2
Personal	10,614		6.3		16,368		10.6		17,562		4.5		32,005		9.4
Total Property	22,777		13.5		31,160		20.1		47,953		12.3		61,720		18.1

Casualty
General Liability	33,741		20.0		27,517		17.8		55,398		14.3		48,076		14.1
Motor Liability	8,638		5.1		2,707		1.7		14,656		3.8		8,306		2.4
Professional Liability	(448)		(0.3)		2,625		1.7		119		—		6,272		1.8
Workers' Compensation	(40)		—		3,899		2.5		3,380		0.9		7,058		2.1
Multi-line	38,314		22.7		51,724		33.4		113,441		29.4		105,884		31.0
Total Casualty	80,205		47.5		88,472		57.1		186,994		48.4		175,596		51.4

Other
Accident & Health	2,947		1.7		2,013		1.3		3,878		1.0		4,489		1.3
Financial	17,945		10.6		8,850		5.7		38,144		9.9		31,347		9.2
Marine	10,879		6.4		7,854		5.1		30,442		7.9		19,994		5.9
Other Specialty	34,222		20.3		16,594		10.7		78,822		20.5		48,252		14.1
Total Other	65,993		39.1		35,311		22.8		151,286		39.3		104,082		30.5
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

Gross Premiums Written by Geographic Area of Risks Insured


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
U.S. and Caribbean	$	61,786	36.6	%	$	59,588	38.5	%	$	119,160	30.9	%	$	129,440	37.9	%
Worldwide (1)	90,153		53.4		75,131		48.5		234,462		60.7		181,393		53.1
Europe	3,792		2.2		3,641		2.3		8,280		2.1		7,068		2.1
Asia	13,244		7.8		16,583		10.7		24,331		6.3		23,497		6.9
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net income	$ 7,978	$ 49,860	$ 34,997	$ 55,747

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2024
Accounting Policies [Abstract]
Reclassifications	Reclassifications Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.
Recent Accounting Pronouncements	Recently Issued Accounting Standards Not Yet Adopted On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted. On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements. As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.

INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)

6 Months Ended

Jun. 30, 2024

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Financial Information of Investment

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP


	June 30, 2024		December 31, 2023
Assets
Investments, at fair value	$	401,510	$	453,358
Derivative contracts, at fair value	11,244		11,167
Due from brokers	169,898		121,754
Cash and cash equivalents	53,460		—
Interest and dividends receivable	195		1,143
Total assets	636,307		587,422

Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value	(162,984)		(197,571)
Derivative contracts, at fair value	(11,147)		(12,917)
Capital withdrawals payable	—		(1,000)
Due to brokers	—		(17,398)
Interest and dividends payable	(1,404)		(2,315)
Accrued expenses and other liabilities	(164)		(247)
Total liabilities	(175,699)		(231,448)

Partners' capital	$	460,608	$	355,974

GLRE’s share of Partners' capital	$	351,468	$	258,890

Summarized Statements of Operations of Solasglas Investments, LP


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Investment income
Dividend income (net of withholding taxes)	$	941	$	724	$	1,772	$	1,351
Interest income	2,148		2,076		6,500		3,892
Total Investment income	3,089		2,800		8,272		5,243

Expenses
Management fee	(1,408)		(1,163)		(2,731)		(2,231)
Interest	(736)		(1,579)		(2,070)		(3,007)
Dividends	(731)		(793)		(1,435)		(1,212)
Professional fees and other	(335)		(607)		(659)		(889)
Total expenses	(3,210)		(4,142)		(6,895)		(7,339)

Net investment income (loss)	(121)		(1,342)		1,377		(2,096)

Realized and change in unrealized gains (losses)
Net realized gain (loss)	20,085		(845)		63,030		(2,605)
Net change in unrealized appreciation (depreciation)	(13,138)		54,825		(29,383)		53,792
Net gain (loss) on investment transactions	6,947		53,980		33,647		51,187

Net increase (decrease) in Partners' capital (1)	$	6,826	$	52,638	$	35,024	$	49,091

GLRE’s share of the increase (decrease) in Partners' capital	$	4,330	$	32,782	$	22,578	$	29,644

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Management fees	$	1,408	$	1,163	$	2,731	$	2,231
Performance allocation	481		$	3,294	2,509		3,294
Total	$	1,889	$	4,457	$	5,240	$	5,525

OTHER INVESTMENTS (Tables)

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Other Investments

At June 30, 2024, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	27,170	$	49,902	$	(5,206)	$	—	$	71,866
Debt and convertible debt securities	2,713		—		(1,510)		90		1,293

Total other investments	$	29,883	$	49,902	$	(6,716)	$	90	$	73,159

At December 31, 2023, the breakdown of the Company’s other investments was as follows:


	Cost		Unrealized gains		Unrealized losses		Accrued interest		Fair value / carrying value
Private investments and unlisted equities	$	28,470	$	49,424	$	(6,737)	$	—	$	71,157
Debt and convertible debt securities	2,499		—		(499)		136		2,136

Total other investments	$	30,969	$	49,424	$	(7,236)	$	136	$	73,293

Schedule of Carrying Values of Private Investments and Unlisted Equity Securities Carried under Measurement Alternative


	Six months ended June 30
	2024		2023
Carrying value (1)	$	71,866	$	65,904
Upward carrying value changes (2)	$	501	$	506
Downward carrying value changes and impairment (3)	$	(114)	$	(250)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.

(2) The cumulative upward carrying value changes from inception to June 30, 2024, totaled $50.9 million.

(3) The cumulative downward carrying value changes and impairments from inception to June 30, 2024, totaled $2.8 million.

Schedule of Gain (Loss) on Securities

Net investment income


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross realized gains	$	—	$	—	$	—	$	—
Gross realized losses	—		—		(1,332)		(800)
Net realized gains (losses)	$	—	$	—	$	(1,332)	$	(800)
Change in unrealized gains	89		506		1,008		1,056
Net realized and unrealized gains (losses) on other investments	$	89	$	506	$	(324)	$	256

RESTRICTED CASH AND CASH EQUIVALENTS (Tables)

6 Months Ended

Jun. 30, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Restrictions on Cash and Cash Equivalents


	June 30, 2024		December 31, 2023
Restricted cash and cash equivalents:
Cash securing trust accounts	$	274,275	$	300,152
Cash securing letters of credit issued	274,048		291,456
Cash securing Loan Facility	10,000		10,000
Other	3,607		3,040
Total restricted cash and cash equivalents	561,930		604,648
Cash and cash equivalents	52,240		51,082
Total cash, cash equivalents, and restricted cash	$	614,170	$	655,730

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Assets Measured at Fair Value on a Nonrecurring Basis


	Less than 6 months		6 to 12 months		Over 1 year		Total
Fair values measured on a nonrecurring basis	$	1,423	$	26,338	$	34,086	$	61,847

LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)

6 Months Ended

Jun. 30, 2024

Insurance Loss Reserves [Abstract]

Schedule of Liability for Unpaid Claims and Claims Adjustment Expense

The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:


	June 30, 2024		December 31, 2023
Case reserves	$	210,802	$	189,050
IBNR	541,955		472,504
Total	$	752,757	$	661,554

Reserve Roll-forward

The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:


Consolidated	Six months ended June 30
	2024		2023
Gross balance at January 1	$	661,554	$	555,468
Less: Losses recoverable	(25,687)		(13,239)
Net balance at January 1	635,867		542,229
Incurred losses related to:
Current year	206,647		173,428
Prior years	4,712		13,801
Total incurred	211,359		187,229
Paid losses related to:
Current year	(20,677)		(22,428)
Prior years	(129,716)		(114,056)
Total paid	(150,393)		(136,484)
Foreign currency revaluation	(2,723)		6,572
Net balance at June 30	694,110		599,546
Add: Losses recoverable (see Note 8)	58,647		21,555
Gross balance at June 30	$	752,757	$	621,101

RETROCESSION (Tables)

6 Months Ended

Jun. 30, 2024

Reinsurance Disclosures [Abstract]

Ceded Credit Risk

The following table provides a breakdown of ceded reinsurance:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Gross ceded premiums	$	14,832	$	9,739	$	38,013	$	20,951
Earned ceded premiums	$	11,849	$	11,296	$	27,091	$	19,877
Loss and loss adjustment expenses ceded	$	14,773	$	9,537	$	37,849	$	15,708

Effects of Reinsurance

The following table shows a breakdown of losses recoverable on a gross and net of collateral basis:


	June 30, 2024				December 31, 2023
	Gross		Net of Collateral(1)		Gross		Net of Collateral(1)
A- or better by A.M. Best	$	33,288	$	33,288	$	8,767	$	8,767
Not rated	26,059		8,816		17,407		2,432
Total before provision	59,347		$	42,104	$	26,174	$	11,199
Provision for credit losses	(700)				(487)
Total loss and loss adjustment expenses recoverable, net	$	58,647			$	25,687

DEBT AND CREDIT FACILITIES (Tables)

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Schedule of Debt

The following table summarizes the Company’s outstanding debt obligations.


	June 30, 2024		December 31, 2023
Term loans	$	62,188	$	74,062
Accrued interest payable	38		—
Less: deferred financing costs	(631)		(781)
Total debt	$	61,595	$	73,281

Schedule of Letters of Credit Facilities

At June 30, 2024, the Company had the following letter of credit (“LOC”) facilities:


	Capacity		LOCs issued		Termination Date
Citibank Europe plc ("Citi LOC")1	$	289,000	$	231,665	August 20, 2024
CIBC Bank USA ("CIBC LOC")	200,000		42,338		December 21, 2024
	$	489,000	$	274,003

1) Includes $14 million of uncommitted capacity.

SHARE CAPITAL (Tables)

6 Months Ended

Jun. 30, 2024

Equity [Abstract]

Schedule of Stock by Class

The following table is a summary of changes in ordinary shares issued and outstanding for the six months ended June 30:


	2024	2023
	Ordinary	Class A	Class B
Balance – beginning of period	35,336,732	28,569,346	6,254,715
Issue of shares, net of forfeitures	(15,588)	447,952	—



Balance – end of period	35,321,144	29,017,298	6,254,715

SHARE-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Activity for Unvested Restricted Share Awards and Employee Restricted Stock Units

The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the six months ended June 30, 2024 and 2023:


	Performance Restricted Shares			Service Restricted Shares
	Number of non-vested restricted shares	Weighted average grant date fair value		Number of non-vested restricted shares	Weighted average grant date fair value
Balance at December 31, 2022	794,362	$	7.62	832,896	$	7.76
Granted	357,766	9.85		177,563	9.84
Vested	—	—		(256,243)	6.75
Forfeited	(109,105)	9.37		(55,967)	8.43
Balance at June 30, 2023	1,043,023	$	8.20	698,249	$	8.60

Balance at December 31, 2023	1,042,688	$	9.94	419,604	$	9.18
Granted	—	—		—	—
Vested	—	—		(217,522)	8.78
Forfeited	(89,945)	10.84		—	—
Balance at June 30, 2024	952,743	$	9.86	202,082	$	9.61

The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the six months ended June 30, 2024 and 2023:


	Performance RSUs			Service RSUs
	Number of non-vested RSUs	Weighted average grant date fair value		Number of non-vested RSUs	Weighted average grant date fair value
Balance at December 31, 2022	105,008	$	6.82	172,952	$	7.58
Granted	71,121	9.85		42,811	9.85
Vested	—	—		(77,695)	6.74
Forfeited	—	—		(1,788)	7.82
Balance at June 30, 2023	176,129	$	8.04	136,280	$	8.76

Balance at December 31, 2023	154,445	$	8.03	110,425	$	8.78
Granted	258,148	11.85		124,425	11.85
Vested	—	—		(74,357)	8.84
Forfeited	—	—		—	—
Balance at June 30, 2024	412,593	$	10.42	160,493	$	11.14

Schedule of Valuation Assumptions

The following inputs were used in this pricing model:



Expected volatility	36.4		%
Expected term (in years)	5
Expected dividend yield	—		%
Risk-free interest rate	3.9		%
Stock price at grant date	$	11.20

EARNINGS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of Net Income (Loss) and Weighted Average Number of Shares

The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and six months ended June 30, 2024 and 2023:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Numerator for EPS
Net income - basic	$	7,978	$	49,860	$	34,997	$	55,747
Add: interest on convertible notes	—		744		—		1,520
Less: gain on repurchase of convertible notes	—		—		—		(265)
Net income - diluted	$	7,978	$	50,604	$	34,997	$	57,002

Denominator for EPS
Weighted average shares outstanding - basic	34,238,863		34,070,818		34,255,454		34,065,066
Effect of dilutive employee and director share-based awards	460,319		580,494		423,871		534,958
Shares potentially issuable in connection with convertible notes	—		3,615,825		—		3,722,897
Weighted average shares outstanding - diluted	34,699,182		38,267,137		34,679,325		38,322,921
Anti-dilutive stock options outstanding	902,140		690,337		902,140		690,337


EPS:
Basic	$	0.23	$	1.46	$	1.02	$	1.64
Diluted	$	0.23	$	1.32	$	1.01	$	1.49

NET INVESTMENT INCOME (Tables)

6 Months Ended

Jun. 30, 2024

Net Investment Income [Abstract]

Schedule of Other Nonoperating Income (Expense)

The following table provides a breakdown of net investment income:


	Three months ended June 30				Six months ended June 30
	2024		2023		2024		2023
Interest and dividend income, net of withholding taxes and other expenses	$	8,135	$	8,863	$	16,691	$	17,491
Net realized and unrealized gains on other investments (see Note 4)	89		506		(324)		256
Net investment-related income	8,224		9,369		16,367		17,747
Share of Solasglas' net income (see Note 3)	4,330		32,782		22,578		29,644
Total investment income	$	12,554	$	42,151	$	38,945	$	47,391

COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Letters of Credit Facilities

The following table shows the breakdown of reinsurance balances receivable:


	June 30, 2024				December 31, 2023
	Amount		%		Amount		%
Premiums receivable	$	260,801	38.0	%	$	186,940	30.2	%

Funds withheld:
Funds held by cedants	48,790		7.1	%	50,075		8.1	%
Premiums held by Lloyds' syndicates	264,685		38.5	%	264,278		42.7	%
Funds at Lloyd’s	110,624		16.1	%	115,772		18.6	%

Profit commission receivable	2,708		0.4	%	2,302		0.4	%

Deposit assets	—		—	%	888		0.1	%
Total before provision	687,608		100.1	%	620,255		100.1	%
Provision for expected credit losses	(865)		(0.1)	%	(854)		(0.1)	%
Reinsurance balances receivable, net	$	686,743	100.0	%	$	619,401	100.0	%

SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Schedule of Gross Premiums Written by Line of Business

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
Property
Commercial	$	12,070	7.1	%	$	14,440	9.3	%	$	30,236	7.8	%	$	29,131	8.5	%
Motor	93		0.1		352		0.2		155		—		584		0.2
Personal	10,614		6.3		16,368		10.6		17,562		4.5		32,005		9.4
Total Property	22,777		13.5		31,160		20.1		47,953		12.3		61,720		18.1

Casualty
General Liability	33,741		20.0		27,517		17.8		55,398		14.3		48,076		14.1
Motor Liability	8,638		5.1		2,707		1.7		14,656		3.8		8,306		2.4
Professional Liability	(448)		(0.3)		2,625		1.7		119		—		6,272		1.8
Workers' Compensation	(40)		—		3,899		2.5		3,380		0.9		7,058		2.1
Multi-line	38,314		22.7		51,724		33.4		113,441		29.4		105,884		31.0
Total Casualty	80,205		47.5		88,472		57.1		186,994		48.4		175,596		51.4

Other
Accident & Health	2,947		1.7		2,013		1.3		3,878		1.0		4,489		1.3
Financial	17,945		10.6		8,850		5.7		38,144		9.9		31,347		9.2
Marine	10,879		6.4		7,854		5.1		30,442		7.9		19,994		5.9
Other Specialty	34,222		20.3		16,594		10.7		78,822		20.5		48,252		14.1
Total Other	65,993		39.1		35,311		22.8		151,286		39.3		104,082		30.5
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

Schedule of Gross Premiums Written by Geographic Area of Risks Insured

Gross Premiums Written by Geographic Area of Risks Insured


	Three months ended June 30								Six months ended June 30
	2024				2023				2024				2023
U.S. and Caribbean	$	61,786	36.6	%	$	59,588	38.5	%	$	119,160	30.9	%	$	129,440	37.9	%
Worldwide (1)	90,153		53.4		75,131		48.5		234,462		60.7		181,393		53.1
Europe	3,792		2.2		3,641		2.3		8,280		2.1		7,068		2.1
Asia	13,244		7.8		16,583		10.7		24,331		6.3		23,497		6.9
	$	168,975	100.0	%	$	154,943	100.0	%	$	386,233	100.0	%	$	341,398	100.0	%

(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.

INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Aug. 01, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Share of Solasglas' net income (see Note 3)		$ 4,330	$ 32,782	$ 22,578	$ 29,644
Solasglas Investments, LP (SILP)
Schedule of Equity Method Investments [Line Items]
Investment cap percentage				60.00%
Solasglas Investments, LP (SILP) \| Subsequent Event
Schedule of Equity Method Investments [Line Items]
Investment cap percentage	70.00%
Solasglas Investments, LP (SILP) \| GLRE Limited Partners
Schedule of Equity Method Investments [Line Items]
Equity method investments, fair value		$ 351,500		$ 351,500		$ 258,900
Equity method investment, ownership interest (as a percent)		76.30%		76.30%		72.70%
SILP General Partner
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership interest (as a percent)		23.70%		23.70%		27.30%

INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets
Investments, at fair value	$ 351,468	$ 258,890
Cash and cash equivalents	52,240	51,082
Total assets	1,899,948	1,735,307
Liabilities
Accrued expenses and other liabilities	(8,042)	(11,795)
Total liabilities	(1,265,928)	(1,139,212)
Solasglas Investments, LP (SILP)
Assets
Investments, at fair value	401,510	453,358
Derivative contracts, at fair value	11,244	11,167
Due from brokers	169,898	121,754
Cash and cash equivalents	53,460	0
Interest and dividends receivable	195	1,143
Total assets	636,307	587,422
Liabilities
Investments sold short, at fair value	(162,984)	(197,571)
Derivative contracts, at fair value	(11,147)	(12,917)
Capital withdrawals payable	0	(1,000)
Due to brokers	0	(17,398)
Interest and dividends payable	(1,404)	(2,315)
Accrued expenses and other liabilities	(164)	(247)
Total liabilities	(175,699)	(231,448)
Partners' capital	$ 460,608	$ 355,974

INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Expenses
Total expenses	$ (166,450)	$ (139,801)	$ (330,225)	$ (288,846)
Net investment income (loss)	8,224	9,369	16,367	17,747
Realized and change in unrealized gains (losses)
Net change in unrealized appreciation (depreciation)			1,500
Net gain (loss) on investment transactions	89	506	(324)	256
Net increase (decrease) in Partners' capital	7,978	49,860	34,997	55,747
GLRE’s share of the increase (decrease) in Partners' capital	4,330	32,782	22,578	29,644
Management fees	1,408	1,163	2,731	2,231
Performance allocation	481	3,294	2,509	3,294
Total	1,889	4,457	5,240	5,525
Solasglas Investments, LP (SILP)
Realized and change in unrealized gains (losses)
GLRE’s share of the increase (decrease) in Partners' capital	4,330	32,782	22,578	29,644
Solasglas Investments, LP (SILP)
Investment income
Dividend income (net of withholding taxes)	941	724	1,772	1,351
Interest income	2,148	2,076	6,500	3,892
Total Investment income	3,089	2,800	8,272	5,243
Expenses
Management fee	(1,408)	(1,163)	(2,731)	(2,231)
Interest	(736)	(1,579)	(2,070)	(3,007)
Dividends	(731)	(793)	(1,435)	(1,212)
Professional fees and other	(335)	(607)	(659)	(889)
Total expenses	(3,210)	(4,142)	(6,895)	(7,339)
Net investment income (loss)	(121)	(1,342)	1,377	(2,096)
Realized and change in unrealized gains (losses)
Net realized gain (loss)	20,085	(845)	63,030	(2,605)
Net change in unrealized appreciation (depreciation)	(13,138)	54,825	(29,383)	53,792
Net gain (loss) on investment transactions	6,947	53,980	33,647	51,187
Net increase (decrease) in Partners' capital	$ 6,826	$ 52,638	$ 35,024	$ 49,091

OTHER INVESTMENTS - Other Investments (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Debt and Equity Securities, FV-NI
Cost	$ 29,883	$ 30,969
Unrealized gains	49,902	49,424
Unrealized losses	(6,716)	(7,236)
Accrued interest	90	136
Fair value / carrying value	73,159	73,293
Private investments and unlisted equities
Debt and Equity Securities, FV-NI
Cost	27,170	28,470
Unrealized gains	49,902	49,424
Unrealized losses	(5,206)	(6,737)
Accrued interest	0	0
Fair value / carrying value	71,866	71,157
Debt and convertible debt securities
Debt and Equity Securities, FV-NI
Cost	2,713	2,499
Unrealized gains	0	0
Unrealized losses	(1,510)	(499)
Accrued interest	90	136
Fair value / carrying value	$ 1,293	$ 2,136

OTHER INVESTMENTS - Nonrecurring Fair Value Disclosures (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value
Upward carrying value changes	$ 50,900
Downward carrying value changes and impairment	(2,800)
Fair Value, Nonrecurring
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value
Carrying value	71,866	$ 65,904
Upward carrying value changes	501	506
Downward carrying value changes and impairment	$ (114)	$ (250)

OTHER INVESTMENTS - Net Investment Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Gross realized gains	$ 0	$ 0	$ 0	$ 0
Gross realized losses	0	0	(1,332)	(800)
Net realized gains (losses)	0	0	(1,332)	(800)
Change in unrealized gains	89	506	1,008	1,056
Net gain (loss) on investment transactions	$ 89	$ 506	$ (324)	$ 256

OTHER INVESTMENTS - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Liquidation proceeds relating to a private investment			$ 168	$ 6,000
Gross realized loss	$ 0	$ 0	1,332	800
Unrealized gain			$ 1,500
Realized loss		$ 0		$ 800

RESTRICTED CASH AND CASH EQUIVALENTS (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash and cash equivalents	$ 561,930	$ 604,648
Cash and cash equivalents	52,240	51,082
Total cash, cash equivalents, and restricted cash	614,170	655,730	$ 683,331	$ 706,548
Cash securing trust accounts
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash and cash equivalents	274,275	300,152
Cash securing letters of credit issued
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash and cash equivalents	274,048	291,456
Cash securing Loan Facility
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash and cash equivalents	10,000	10,000
Other
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash and cash equivalents	$ 3,607	$ 3,040

FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Other investments	$ 73,159	$ 73,159	$ 73,293
Percentage of interest rate risk hedged	50.00%	50.00%
Unrealized gain on derivatives	$ 100	$ 600
Private investments and unlisted equities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Other investments	10,000	10,000	9,900
Fair Value, Nonrecurring
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Fair value / carrying value	$ 61,800	$ 61,800	$ 61,300

FAIR VALUE MEASUREMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details) $ in Thousands	Jun. 30, 2024 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Fair values measured on a nonrecurring basis	$ 61,847
Measurement Period One
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Fair values measured on a nonrecurring basis	1,423
Measurement Period Two
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Fair values measured on a nonrecurring basis	26,338
Measurement Period Three
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Fair values measured on a nonrecurring basis	$ 34,086

LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Insurance Loss Reserves [Abstract]
Case reserves	$ 210,802		$ 189,050
IBNR	541,955		472,504
Total	752,757	$ 621,101	661,554	$ 555,468
Liability for Unpaid Claims and Claims Adjustment Expense
Gross balance at January 1	661,554	555,468
Less: Losses recoverable			(25,687)	$ (13,239)
Net balance at January 1	635,867	542,229
Incurred losses related to:
Current year	206,647	173,428
Prior years	4,712	13,801
Total incurred	211,359	187,229
Paid losses related to:
Current year	(20,677)	(22,428)
Prior years	(129,716)	(114,056)
Total paid	(150,393)	(136,484)
Foreign currency revaluation	(2,723)	6,572
Net balance at June 30	694,110	599,546
Add: Losses recoverable (see Note 8)	58,647	21,555	$ 25,687
Gross balance at June 30	$ 752,757	$ 621,101

LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Liability for Claims and Claims Adjustment Expense
Prior years	$ 4,712	$ 13,801
Reinsurance Contract [Axis]: Expected Loss
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)		(7,700)
Reinsurance Contract [Axis]: Favorable Loss
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)	(14,800)
Reinsurance Contract [Axis]: Newly Reported Loss
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)	19,500
Reinsurance Contract [Axis]: Reserve Strengthening
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)		21,500
CAT Losses
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)	35,200	19,600
Baltimore Bridge Collapse, Severe US Tornados, Satellite Failures, Mexican State-owned Oil Platform Fire
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)	25,700
Turkey Earthquake, New Zealand Cyclone Gabrielle, Severe U.S. Tornados
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)		16,400
CAT Development
Liability for Claims and Claims Adjustment Expense
Net loss reserve on prior contracts increase (decrease)	$ (9,400)	$ (3,200)

RETROCESSION - Ceded Reinsurance (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Reinsurance Disclosures [Abstract]
Gross ceded premiums	$ 14,832	$ 9,739	$ 38,013	$ 20,951
Earned ceded premiums	11,849	11,296	27,091	19,877
Loss and loss adjustment expenses ceded	$ 14,773	$ 9,537	$ 37,849	$ 15,708

RETROCESSION - Breakdown of Losses Recoverable on a Gross and Net of Collateral Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Ceded Credit Risk
Provision for credit losses	$ (865)	$ (854)
Total loss and loss adjustment expenses recoverable, net		25,687	$ 13,239
Retrocession Portfolio
Ceded Credit Risk
Total before provision	59,347	26,174
Provision for credit losses	(700)	(487)
Total loss and loss adjustment expenses recoverable, net	58,647	25,687
Net of Collateral	42,104	11,199
A- or better by A.M. Best \| Retrocession Portfolio
Ceded Credit Risk
Total before provision	33,288	8,767
Net of Collateral	33,288	8,767
Not rated \| Retrocession Portfolio
Ceded Credit Risk
Total before provision	26,059	17,407
Net of Collateral	$ 8,816	$ 2,432

RETROCESSION - Narrative (Details) - Three Reinsurers - Total Loss and Loss Adjustment Expense Recoverability - Reinsurance Concentration Risk - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Ceded Credit Risk
Concentration risk percentage	10.00%	10.00%
Loss and loss adjustment expenses ceded	$ 42.3	$ 20.4

DEBT AND CREDIT FACILITIES - Debt Obligations (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Term loans	$ 62,188	$ 74,062
Accrued interest payable	38	0
Less: deferred financing costs	(631)	(781)
Total debt	$ 61,595	$ 73,281

DEBT AND CREDIT FACILITIES - Narrative (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Apr. 12, 2024
Line of Credit Facility [Line Items]
Committed capacity under the Citi LOC agreement	$ 489,000,000
Term Loan
Line of Credit Facility [Line Items]
Repayments of debt	(11,900,000)
Financial Standby Letter of Credit \| Citibank Europe plc ("Citi LOC")1
Line of Credit Facility [Line Items]
Committed capacity under the Citi LOC agreement	$ 289,000,000	$ 275,000,000

DEBT AND CREDIT FACILITIES - Letter of Credit (“LOC”) Facilities (Details) - USD ($)	Jun. 30, 2024	Apr. 12, 2024
Line of Credit Facility [Line Items]
Capacity	$ 489,000,000
Financial Standby Letter of Credit
Line of Credit Facility [Line Items]
LOCs issued	274,003,000
Financial Standby Letter of Credit \| Citibank Europe plc ("Citi LOC")1
Line of Credit Facility [Line Items]
Capacity	289,000,000	$ 275,000,000
LOCs issued	231,665,000
Uncommitted capacity	14,000,000
Financial Standby Letter of Credit \| CIBC Bank USA ("CIBC LOC")
Line of Credit Facility [Line Items]
Capacity	200,000,000
LOCs issued	$ 42,338,000

SHARE CAPITAL - Stock by Class (Details) - shares	6 Months Ended
SHARE CAPITAL - Stock by Class (Details) - shares	Jun. 30, 2024	Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity
Balance – beginning of period (in shares)	35,336,732
Issue of shares, net of forfeitures (in shares)	(15,588)
Balance – end of period (in shares)	35,321,144
Class A
Increase (Decrease) in Stockholders' Equity
Balance – beginning of period (in shares)		28,569,346
Issue of shares, net of forfeitures (in shares)		447,952
Balance – end of period (in shares)		29,017,298
Class B
Increase (Decrease) in Stockholders' Equity
Balance – beginning of period (in shares)		6,254,715
Issue of shares, net of forfeitures (in shares)		0
Balance – end of period (in shares)		6,254,715

SHARE CAPITAL - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	May 03, 2024	Dec. 31, 2023
Equity [Abstract]
Ordinary share capital, authorized (in shares)	125,000,000
Ordinary share capital, par value (in dollars per share)	$ 0.10			$ 0.10
Aggregate principal amount	$ 200.0
Stock repurchase program, authorized amount			$ 25.0
Repurchase of ordinary shares (in shares)	0	0
Preferred share capital, authorized (in shares)	50,000,000
Preferred share capital, par value (in dollars per share)	$ 0.10			$ 0.10

SHARE-BASED COMPENSATION - Restricted Stock (Details) - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Performance Restricted Shares
Number of non-vested RSUs
Beginning balance (in shares)	1,042,688	794,362
Granted (in shares)	0	357,766
Vested (in shares)	0	0
Forfeited (in shares)	(89,945)	(109,105)
Ending balance (in shares)	952,743	1,043,023
Weighted average grant date fair value
Beginning balance (in dollars per share)	$ 9.94	$ 7.62
Granted (in dollars per share)	0	9.85
Vested (in dollars per share)	0	0
Forfeited (in dollars per share)	10.84	9.37
Ending balance (in dollars per share)	$ 9.86	$ 8.20
Service Restricted Shares
Number of non-vested RSUs
Beginning balance (in shares)	419,604	832,896
Granted (in shares)	0	177,563
Vested (in shares)	(217,522)	(256,243)
Forfeited (in shares)	0	(55,967)
Ending balance (in shares)	202,082	698,249
Weighted average grant date fair value
Beginning balance (in dollars per share)	$ 9.18	$ 7.76
Granted (in dollars per share)	0	9.84
Vested (in dollars per share)	8.78	6.75
Forfeited (in dollars per share)	0	8.43
Ending balance (in dollars per share)	$ 9.61	$ 8.60

SHARE-BASED COMPENSATION - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance (in shares)	2,914,198		3,296,771
Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	250,000
Grants (in dollars per share)	$ 4.31
General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense, net of forfeiture reversals	$ 2.9	$ 2.3
Employee and Director Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted to employees RSUs (in shares)	0	535,329
Total fair value of restricted shares vested	$ 1.9	$ 1.7
Performance RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted to employees RSUs (in shares)	258,148	71,121
Total fair value of restricted shares vested	$ 0.7	$ 0.5
Cliff vesting period after date of issuance	3 years
Cliff vesting percentage after date of issuance (in percent)	100.00%
Performance RSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting percentage after date of issuance (in percent)	50.00%
Performance RSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting percentage after date of issuance (in percent)	200.00%
Anti-dilutive stock options outstanding \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting period after date of issuance	10 years
Number of options exercisable (in shares)	50,000
Performance Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted to employees RSUs (in shares)	0	357,766

SHARE-BASED COMPENSATION - Restricted Stock Units (Details) - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Performance RSUs
Number of non-vested RSUs
Beginning balance (in shares)	154,445	105,008
Granted (in shares)	258,148	71,121
Vested (in shares)	0	0
Forfeited (in shares)	0	0
Ending balance (in shares)	412,593	176,129
Weighted average grant date fair value
Beginning balance (in dollars per share)	$ 8.03	$ 6.82
Granted (in dollars per share)	11.85	9.85
Vested (in dollars per share)	0	0
Forfeited (in dollars per share)	0	0
Ending balance (in dollars per share)	$ 10.42	$ 8.04
Service RSUs
Number of non-vested RSUs
Beginning balance (in shares)	110,425	172,952
Granted (in shares)	124,425	42,811
Vested (in shares)	(74,357)	(77,695)
Forfeited (in shares)	0	(1,788)
Ending balance (in shares)	160,493	136,280
Weighted average grant date fair value
Beginning balance (in dollars per share)	$ 8.78	$ 7.58
Granted (in dollars per share)	11.85	9.85
Vested (in dollars per share)	8.84	6.74
Forfeited (in dollars per share)	0	7.82
Ending balance (in dollars per share)	$ 11.14	$ 8.76

SHARE-BASED COMPENSATION - Schedule of Valuation Assumptions (Details) - Chief Executive Officer	6 Months Ended
	Jun. 30, 2024 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	36.40%
Expected term (in years)	5 years
Expected dividend yield	0.00%
Risk-free interest rate	3.90%
Stock price at grant date	$ 11.20

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator for EPS
Net income - basic	$ 7,978	$ 49,860	$ 34,997	$ 55,747
Add: interest on convertible notes	0	744	0	1,520
Less: gain on repurchase of convertible notes	0	0	0	(265)
Net income - diluted	$ 7,978	$ 50,604	$ 34,997	$ 57,002
Denominator for EPS
Weighted average shares outstanding - basic (in shares)	34,238,863	34,070,818	34,255,454	34,065,066
Effect of dilutive employee and director share-based awards (in shares)	460,319	580,494	423,871	534,958
Shares potentially issuable in connection with convertible notes (in shares)	0	3,615,825	0	3,722,897
Weighted average shares outstanding - diluted (in shares)	34,699,182	38,267,137	34,679,325	38,322,921
EPS:
Basic (in dollars per share)	$ 0.23	$ 1.46	$ 1.02	$ 1.64
Diluted (in dollars per share)	$ 0.23	$ 1.32	$ 1.01	$ 1.49
Anti-dilutive stock options outstanding
Denominator for EPS
Anti-dilutive stock options outstanding (in shares)	902,140	690,337	902,140	690,337

NET INVESTMENT INCOME (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
NET INVESTMENT INCOME (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Net Investment Income [Abstract]
Interest and dividend income, net of withholding taxes and other expenses	$ 8,135	$ 8,863	$ 16,691	$ 17,491
Net realized and unrealized gains on other investments (see Note 4)	89	506	(324)	256
Net investment-related income	8,224	9,369	16,367	17,747
Share of Solasglas' net income (see Note 3)	4,330	32,782	22,578	29,644
Total investment income	$ 12,554	$ 42,151	$ 38,945	$ 47,391

RELATED PARTY TRANSACTIONS (Details) - USD ($) shares in Millions		6 Months Ended
	Jan. 01, 2019	Jun. 30, 2024	Jul. 31, 2024
Affiliated Entity \| Green Bricks Partners Inc (GRBK) \| Solasglas Investments, LP (SILP)
Related Party Transaction
Common stock held (in shares)		1.8
Affiliated Entity \| Green Bricks Partners Inc (GRBK) \| Solasglas Investments, LP (SILP) \| Subsequent Event
Related Party Transaction
Common stock held (in shares)			1.3
Affiliated Entity \| Green Bricks Partners Inc (GRBK) \| Solasglas Investments, LP (SILP)
Related Party Transaction
Ownership percentage (in percent)		25.20%
Service Agreement \| Board of Directors Chairman
Related Party Transaction
Investor relations monthly fee		$ 5,000
Contract termination prior notice period (in days)		30 days
Collateral Assets Investment Management Agreement \| Board of Directors Chairman
Related Party Transaction
Contract termination prior notice period (in days)	30 days

COMMITMENTS AND CONTINGENCIES - Breakdown of Reinsurance Balances Receivable (Details) $ in Thousands	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Amount
Premiums receivable	$ 260,801	$ 186,940
Funds held by cedants	48,790	50,075
Premiums held by Lloyds' syndicates	264,685	264,278
Funds at Lloyd’s	110,624	115,772
Profit commission receivable	2,708	2,302
Deposit assets	0	888
Total before provision	687,608	620,255
Provision for credit losses	(865)	(854)
Reinsurance balances receivable, net	$ 686,743	$ 619,401
%
Premiums receivable	0.380	0.302
Funds held by cedants	7.10%	8.10%
Premiums held by Lloyds' syndicates	0.385	0.427
Funds at Lloyd’s	0.161	0.186
Profit commission receivable	0.004	0.004
Deposit assets	0	0.001
Total before provision	1.001	1.001
Provision for expected credit losses	(0.001)	(0.001)
Reinsurance balances receivable, net	1.000	1.000

SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) segment	Jun. 30, 2023 USD ($)
Segment Reporting Information
Number of operating segments \| segment			1
Gross premiums written	$ 168,975	$ 154,943	$ 386,233	$ 341,398
Gross premiums written (in percent)	100.00%	100.00%	100.00%	100.00%
Total Property
Segment Reporting Information
Gross premiums written	$ 22,777	$ 31,160	$ 47,953	$ 61,720
Gross premiums written (in percent)	13.50%	20.10%	12.30%	18.10%
Commercial
Segment Reporting Information
Gross premiums written	$ 12,070	$ 14,440	$ 30,236	$ 29,131
Gross premiums written (in percent)	7.10%	9.30%	7.80%	8.50%
Motor
Segment Reporting Information
Gross premiums written	$ 93	$ 352	$ 155	$ 584
Gross premiums written (in percent)	0.10%	0.20%	0.00%	0.20%
Personal
Segment Reporting Information
Gross premiums written	$ 10,614	$ 16,368	$ 17,562	$ 32,005
Gross premiums written (in percent)	6.30%	10.60%	4.50%	9.40%
Total Casualty
Segment Reporting Information
Gross premiums written	$ 80,205	$ 88,472	$ 186,994	$ 175,596
Gross premiums written (in percent)	47.50%	57.10%	48.40%	51.40%
General Liability
Segment Reporting Information
Gross premiums written	$ 33,741	$ 27,517	$ 55,398	$ 48,076
Gross premiums written (in percent)	20.00%	17.80%	14.30%	14.10%
Motor Liability
Segment Reporting Information
Gross premiums written	$ 8,638	$ 2,707	$ 14,656	$ 8,306
Gross premiums written (in percent)	5.10%	1.70%	3.80%	2.40%
Professional Liability
Segment Reporting Information
Gross premiums written	$ (448)	$ 2,625	$ 119	$ 6,272
Gross premiums written (in percent)	(0.30%)	1.70%	0.00%	1.80%
Workers' Compensation
Segment Reporting Information
Gross premiums written	$ (40)	$ 3,899	$ 3,380	$ 7,058
Gross premiums written (in percent)	0.00%	2.50%	0.90%	2.10%
Multi-line
Segment Reporting Information
Gross premiums written	$ 38,314	$ 51,724	$ 113,441	$ 105,884
Gross premiums written (in percent)	22.70%	33.40%	29.40%	31.00%
Total Other
Segment Reporting Information
Gross premiums written	$ 65,993	$ 35,311	$ 151,286	$ 104,082
Gross premiums written (in percent)	39.10%	22.80%	39.30%	30.50%
Accident & Health
Segment Reporting Information
Gross premiums written	$ 2,947	$ 2,013	$ 3,878	$ 4,489
Gross premiums written (in percent)	1.70%	1.30%	1.00%	1.30%
Financial
Segment Reporting Information
Gross premiums written	$ 17,945	$ 8,850	$ 38,144	$ 31,347
Gross premiums written (in percent)	10.60%	5.70%	9.90%	9.20%
Marine
Segment Reporting Information
Gross premiums written	$ 10,879	$ 7,854	$ 30,442	$ 19,994
Gross premiums written (in percent)	6.40%	5.10%	7.90%	5.90%
Other Specialty
Segment Reporting Information
Gross premiums written	$ 34,222	$ 16,594	$ 78,822	$ 48,252
Gross premiums written (in percent)	20.30%	10.70%	20.50%	14.10%

SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue from External Customer
Gross premiums written	$ 168,975	$ 154,943	$ 386,233	$ 341,398
Gross premiums by geographical area as a percentage of total gross premiums			100.00%	100.00%
Gross premiums written (in percent)	100.00%	100.00%	100.00%	100.00%
U.S. and Caribbean
Revenue from External Customer
Gross premiums written	$ 61,786	$ 59,588	$ 119,160	$ 129,440
Gross premiums by geographical area as a percentage of total gross premiums			30.90%	37.90%
Gross premiums written (in percent)	36.60%	38.50%
Worldwide
Revenue from External Customer
Gross premiums written	$ 90,153	$ 75,131	$ 234,462	$ 181,393
Gross premiums by geographical area as a percentage of total gross premiums			60.70%	53.10%
Gross premiums written (in percent)	53.40%	48.50%
Europe
Revenue from External Customer
Gross premiums written	$ 3,792	$ 3,641	$ 8,280	$ 7,068
Gross premiums by geographical area as a percentage of total gross premiums			2.10%	2.10%
Gross premiums written (in percent)	2.20%	2.30%
Asia
Revenue from External Customer
Gross premiums written	$ 13,244	$ 16,583	$ 24,331	$ 23,497
Gross premiums by geographical area as a percentage of total gross premiums			6.30%	6.90%
Gross premiums written (in percent)	7.80%	10.70%